@NP	A Clonal Cell Line from Immortalized Olfactory Ensheathing Glia	1
@NP	A Clonal Cell Line	1
@NP	Olfactory Ensheathing Glia	38
@NP	Functional Recovery	74
@NP	the Injured Spinal Cord M.	97
@NP	the	97
@NP	Spinal Cord M.	109
@NP	Teresa Moreno -- Flores ,1 Elizabeth J.	125
@NP	Teresa Moreno	125
@NP	Flores ,1 Elizabeth J.	139
@NP	Bradbury ,2 M.	161
@NP	Bradbury ,2	161
@NP	M.	172
@NP	Jesu ' s	175
@NP	Jesu '	175
@NP	Martı '	183
@NP	n-Bermejo ,1 Marta Agudo ,2 Filip Lim ,1 E ' rika Pastrana ,1 Jesu 's A '	189
@NP	n-Bermejo	189
@NP	,1 Marta Agudo ,2 Filip Lim ,1 E ' rika Pastrana ,1 Jesu 's A '	198
@NP	,1 Marta Agudo ,2	198
@NP	Lim ,1	221
@NP	E ' rika Pastrana ,1 Jesu 's A	227
@NP	E ' rika Pastrana ,1	227
@NP	E ' rika	227
@NP	E '	227
@NP	Pastrana ,1	235
@NP	Jesu 's A	246
@NP	Jesu 's	246
@NP	A	253
@NP	vila ,1 Javier Dı ' az-Nido ,1 Stephen B.	256
@NP	vila ,1 Javier	256
@NP	Dı ' az-Nido ,1 Stephen B.	270
@NP	Dı '	270
@NP	az-Nido ,1 Stephen B.	273
@NP	,1	280
@NP	McMahon	294
@NP	,2 and Francisco Wandosell 1 , *	301
@NP	,2	301
@NP	Francisco Wandosell 1	308
@NP	Francisco Wandosell	308
@NP	1	328
@NP	1Centro de Biologı	332
@NP	a Molecular b	351
@NP	Severo Ochoa	365
@NP	Q Facultad de Ciencias	378
@NP	Universidad Auto ' noma de Madrid	402
@NP	Universidad Auto ' noma	402
@NP	Universidad Auto '	402
@NP	Madrid	427
@NP	28049 Madrid	435
@NP	Spain 2Sensory Function Group	449
@NP	Centre for Neuroscience Research	480
@NP	Centre	480
@NP	Neuroscience Research	491
@NP	Hodgkin Building	514
@NP	Kings College London , Guy 's Campus	532
@NP	Kings College London	532
@NP	Guy 's Campus	554
@NP	Guy 's	554
@NP	London Bridge SE1 1UL	568
@NP	UK	591
@NP	cell lines of olfactory ensheathing glia	608
@NP	cell lines	608
@NP	olfactory ensheathing glia	622
@NP	OEG	650
@NP	the proregenerative properties of primary cultures	669
@NP	the proregenerative properties	669
@NP	primary cultures	703
@NP	an unlimited source of OEG for both basic and applied studies	728
@NP	an unlimited source	728
@NP	OEG for both basic and applied studies	751
@NP	OEG	751
@NP	both basic and applied studies	759
@NP	one specific	799
@NP	one	799
@NP	rat OEG clonal line -LRB- TEG3 -RRB- proved to be as good	825
@NP	rat OEG	825
@NP	clonal line -LRB- TEG3 -RRB-	833
@NP	clonal line	833
@NP	TEG3	846
@NP	primary OEG	876
@NP	neuritogenesis and axon regeneration	901
@NP	culture models	941
@NP	we	963
@NP	the capacity of TEG3	975
@NP	the capacity	975
@NP	TEG3	991
@NP	axonal repair	1007
@NP	an animal model of spinal cord injury , dorsal column crush	1024
@NP	an animal model	1024
@NP	spinal cord injury , dorsal column crush	1043
@NP	spinal cord injury	1043
@NP	dorsal column crush	1063
@NP	TEG3 cells	1084
@NP	astrocyte-like or Schwann cell-like morphology	1107
@NP	astrocyte-like	1107
@NP	Schwann cell-like morphology	1125
@NP	the conditions under which they are cultured	1167
@NP	the conditions	1167
@NP	they	1194
@NP	the injured spinal cord	1216
@NP	prelabeled TEG3	1241
@NP	at least 10 weeks	1270
@NP	they	1307
@NP	the spinal cord	1328
@NP	Schwann cell-like , astrocyte-like , or intermediate morphologies	1354
@NP	Schwann	1354
@NP	intermediate morphologies	1392
@NP	TEG3-transplanted animals	1422
@NP	sensory projection axons	1449
@NP	the lesion site	1484
@NP	there	1504
@NP	robust sprouting/axonal growth of the corticospinal tract	1514
@NP	robust sprouting/axonal growth	1514
@NP	the corticospinal tract	1548
@NP	the lesion site	1594
@NP	the spinal cord -- dorsal columns	1629
@NP	the spinal cord	1629
@NP	dorsal columns	1645
@NP	TEG3-transplanted animals	1661
@NP	sensory and motor function	1702
@NP	tape removal and beam walking behavioral tests	1732
@NP	These data	1780
@NP	certain immortalized cell lines derived from a single cell	1805
@NP	certain	1805
@NP	cell lines derived from a single cell	1826
@NP	cell lines	1826
@NP	a single cell	1850
@NP	the regenerative properties of primary OEG	1877
@NP	the regenerative properties	1877
@NP	primary OEG	1908
@NP	INTRODUCTION	1922
@NP	Cajal 's pioneering studies	1941
@NP	Cajal 's	1941
@NP	it	1969
@NP	neurons from the central nervous system -LRB- CNS -RRB-	1997
@NP	neurons	1997
@NP	the central nervous system -LRB- CNS -RRB-	2010
@NP	the central nervous system	2010
@NP	CNS	2038
@NP	contrast	2065
@NP	those from the peripheral nervous system -LSB- 1 -RSB-	2077
@NP	those	2077
@NP	the peripheral nervous system -LSB- 1 -RSB-	2088
@NP	the peripheral nervous system	2088
@NP	1 -RSB-	2119
@NP	Several strategies	2123
@NP	CNS regeneration	2166
@NP	axonal growth inhibitors	2215
@NP	myelin or glial scar or cell transplantation	2245
@NP	-LSB- 2 -- 9 -RSB-	2301
@NP	-LSB- 2	2301
@NP	the past few years	2324
@NP	olfactory ensheathing glia -LRB- OEG -RRB-	2344
@NP	olfactory ensheathing glia	2344
@NP	OEG	2372
@NP	much attention with respect	2391
@NP	much attention	2391
@NP	respect	2411
@NP	CNS regeneration	2422
@NP	their special properties -LSB- 2,5,6 -RSB-	2446
@NP	their special properties	2446
@NP	2,5,6 -RSB-	2472
@NP	One facet that distinguishes the mammalian olfactory system	2480
@NP	the mammalian olfactory system	2509
@NP	adult life	2559
@NP	olfactory sensory neurons	2571
@NP	progenitor cells of the olfactory neuroepithelium	2631
@NP	progenitor cells	2631
@NP	the olfactory neuroepithelium	2651
@NP	these neurons	2695
@NP	new axons	2716
@NP	their targets	2745
@NP	the olfactory bulb -LSB- 10	2762
@NP	the olfactory bulb	2762
@NP	10	2782
@NP	13 -RSB-	2785
@NP	OEG usually ensheathe olfactory axons	2796
@NP	OEG	2796
@NP	ensheathe olfactory axons	2808
@NP	the adult mammalian CNS	2847
@NP	it	2872
@NP	they	2905
@NP	axonal regeneration	2927
@NP	the injured CNS -LSB- 14,15 -RSB-	2950
@NP	the injured CNS	2950
@NP	14,15 -RSB-	2967
@NP	the regenerative capacity of these cells in the injured spinal cord	2983
@NP	the regenerative capacity	2983
@NP	these cells in the injured spinal cord	3012
@NP	these cells	3012
@NP	the injured spinal cord	3027
@NP	several studies -LSB- 16 -- 19 -RSB-	3073
@NP	several studies	3073
@NP	16 -- 19	3090
@NP	the exact properties and mechanisms	3107
@NP	their effects	3168
@NP	regeneration	3185
@NP	2,5,6,20 -RSB-	3223
@NP	The ability to study OEGs in culture	3234
@NP	OEGs	3255
@NP	culture	3263
@NP	the characterization of their regenerative activity	3283
@NP	the characterization	3283
@NP	their regenerative activity	3307
@NP	many in vivo studies	3345
@NP	many	3345
@NP	vivo studies	3353
@NP	the optimal conditions for their therapeutic use -LRB- if any -RRB-	3394
@NP	the optimal conditions	3394
@NP	their therapeutic use -LRB- if any -RRB-	3421
@NP	their therapeutic use	3421
@NP	any	3447
@NP	CNS injuries	3455
@NP	some doubts	3477
@NP	the relationship	3512
@NP	the OEG	3537
@NP	vivo	3548
@NP	the olfactory system and their counterparts	3556
@NP	the olfactory system	3556
@NP	their counterparts	3581
@NP	culture	3603
@NP	-LSB- 5 -RSB-	3616
@NP	Continuous preparation of OEG primary cultures	3622
@NP	Continuous preparation	3622
@NP	OEG primary cultures	3648
@NP	it	3701
@NP	batch-to-batch variability	3718
@NP	the cell numbers	3750
@NP	it	3800
@NP	the heterogeneity of mixed populations of primary olfactory cell cultures	3826
@NP	the heterogeneity	3826
@NP	mixed populations of primary olfactory cell cultures	3847
@NP	mixed populations	3847
@NP	primary olfactory cell cultures	3868
@NP	transplants	3917
@NP	CNS repair	3940
@NP	5,20 -RSB-	3964
@NP	it	3971
@NP	access	3995
@NP	pure homogeneous OEG populations that can be more completely characterized	4005
@NP	pure homogeneous OEG populations	4005
@NP	the different methods	4089
@NP	OEG cells -LSB- 14,16	4169
@NP	OEG cells	4169
@NP	14,16	4180
@NP	19,21	4186
@NP	subtle differences in the isolation and preparation of OEG	4197
@NP	subtle differences	4197
@NP	the isolation and preparation of OEG	4219
@NP	the isolation and preparation	4219
@NP	OEG	4252
@NP	no two laboratories	4266
@NP	fully comparable cells	4299
@NP	Immortalized clonal cell lines	4323
@NP	the capacity	4366
@NP	axonal regeneration of primary OEG cultures	4390
@NP	axonal regeneration	4390
@NP	primary OEG cultures	4413
@NP	an unlimited supply of homogeneous OEG cells -LSB- 6,26 -- 28 -RSB-	4461
@NP	an unlimited supply	4461
@NP	homogeneous OEG cells -LSB- 6,26 -- 28 -RSB-	4484
@NP	homogeneous OEG cells	4484
@NP	6,26 -- 28	4507
@NP	we	4525
@NP	the immortalization of primary rat OEG	4549
@NP	the immortalization	4549
@NP	primary rat OEG	4572
@NP	the establishment of several clonal cell lines	4592
@NP	the establishment	4592
@NP	several clonal cell lines	4613
@NP	Some of these	4640
@NP	Some	4640
@NP	these	4648
@NP	primary OEG	4670
@NP	neuritogenesis and axonal regeneration in culture	4695
@NP	neuritogenesis and axonal regeneration	4695
@NP	culture	4737
@NP	the most potent of them being TEG3 -LSB- 29,30 -RSB-	4746
@NP	the most potent	4746
@NP	them	4765
@NP	TEG3 -LSB- 29,30 -RSB-	4776
@NP	TEG3	4776
@NP	29,30 -RSB-	4782
@NP	we	4795
@NP	the morphology of TEG3 cells	4808
@NP	the morphology	4808
@NP	TEG3 cells	4826
@NP	a Schwann cell-like phenotype	4863
@NP	an astrocyte-like phenotype	4898
@NP	the composition of the culture medium	4939
@NP	the composition	4939
@NP	the culture medium	4958
@NP	these cells	4988
@NP	an animal model	5005
@NP	CNS injury	5024
@NP	bilateral crushing of the dorsal columns in the rat spinal cord	5036
@NP	bilateral crushing	5036
@NP	the dorsal columns in the rat spinal cord	5058
@NP	the dorsal columns	5058
@NP	the rat spinal cord	5080
@NP	TEG3 cells	5115
@NP	the injured spinal cord for at least 10 weeks	5141
@NP	the injured spinal cord	5141
@NP	at least 10 weeks	5169
@NP	transplantation	5193
@NP	they	5220
@NP	the sites of lesion	5244
@NP	the sites	5244
@NP	lesion	5257
@NP	morphologies	5274
@NP	those found in culture , without forming tumors	5298
@NP	those	5298
@NP	culture	5313
@NP	tumors	5338
@NP	We	5346
@NP	TEG3 cells	5366
@NP	axon repair of sensory and motor tracts	5389
@NP	axon repair	5389
@NP	sensory and motor tracts	5404
@NP	the dorsal columns of the spinal cord	5432
@NP	the dorsal columns	5432
@NP	the spinal cord	5454
@NP	recovery of motor and sensory function	5482
@NP	recovery	5482
@NP	motor and sensory function	5494
@NP	this immortalized OEG clonal line derived from a single cell	5528
@NP	this	5528
@NP	OEG clonal line derived from a single cell	5546
@NP	OEG clonal line	5546
@NP	a single cell	5575
@NP	recovery	5613
@NP	the injured spinal cord	5625
@NP	RESULTS	5651
@NP	1	5664
@NP	The TEG3 clonal line	5667
@NP	immortalization of primary cultures of olfactory ensheathing glia	5704
@NP	immortalization	5704
@NP	primary cultures of olfactory ensheathing glia	5723
@NP	primary cultures	5723
@NP	olfactory ensheathing glia	5743
@NP	the large T antigen of SV40 -LRB- T-SV40 -RRB-	5776
@NP	the large T antigen	5776
@NP	SV40 -LRB- T-SV40 -RRB-	5799
@NP	SV40	5799
@NP	T-SV40	5805
@NP	Immunostaining	5814
@NP	nuclear T-SV40	5833
@NP	the cytoplasmic marker 3-phosphoglycerate dehydrogenase	5860
@NP	red	5917
@NP	TEG3	5932
@NP	different culture media : -LRB- A -RRB- M10 and -LRB- B -RRB- ME3	5955
@NP	different culture media	5955
@NP	-LRB- A -RRB- M10	5980
@NP	-LRB- A -RRB-	5980
@NP	M10	5984
@NP	B	5993
@NP	ME3	5996
@NP	Materials and Methods	6005
@NP	Materials	6005
@NP	Methods	6019
@NP	the TEG3	6039
@NP	cells	6048
@NP	clonal origin , change from a majority of cells -LRB- > 90 % -RRB-	6068
@NP	clonal origin	6068
@NP	change from a majority of cells -LRB- > 90 % -RRB-	6083
@NP	change	6083
@NP	a majority of cells -LRB- > 90 % -RRB-	6095
@NP	a majority	6095
@NP	cells -LRB- > 90 % -RRB-	6109
@NP	cells	6109
@NP	> 90 %	6116
@NP	>	6116
@NP	90 %	6117
@NP	a flat polygonal	6133
@NP	astrocyte-like morphology in M10 -LRB- A -RRB- to a majority -LRB- > 70 % -RRB-	6151
@NP	astrocyte-like morphology in M10 -LRB- A -RRB-	6151
@NP	astrocyte-like morphology	6151
@NP	M10	6180
@NP	A	6185
@NP	a majority -LRB- > 70 % -RRB-	6191
@NP	a majority	6191
@NP	> 70 %	6203
@NP	>	6203
@NP	70 %	6204
@NP	a bipolar , Schwann cell-like morphology in ME3	6214
@NP	a bipolar , Schwann cell-like morphology	6214
@NP	ME3	6257
@NP	B	6262
@NP	Bar , 50 µm .	6266
@NP	Bar	6266
@NP	50 µm	6271
@NP	FIG. 2 .	6279
@NP	FIG.	6279
@NP	2	6284
@NP	The fate	6287
@NP	TEG3 clonal line cells	6299
@NP	the spinal cord after injury and transplant	6325
@NP	the spinal cord	6325
@NP	injury and transplant	6347
@NP	TEG3 cells	6370
@NP	BrdU 18	6401
@NP	20 h	6409
@NP	transplant	6423
@NP	Immunostaining for -LRB- A , B -RRB- BrdU	6435
@NP	Immunostaining	6435
@NP	-LRB- A , B -RRB- BrdU	6454
@NP	A , B	6455
@NP	A	6455
@NP	B	6458
@NP	-LRB- C -RRB- nuclear SV40 large T antigen	6470
@NP	-LRB- C -RRB- nuclear SV40	6470
@NP	C	6471
@NP	large T antigen	6487
@NP	T-SV40	6504
@NP	adjacent sagittal sections -LRB- B , C -RRB-	6524
@NP	adjacent sagittal sections	6524
@NP	B , C	6552
@NP	B	6552
@NP	C	6555
@NP	the lesioned spinal cord	6561
@NP	a representative animal that survived for 4 weeks after transplant	6603
@NP	a representative animal	6603
@NP	4 weeks	6645
@NP	transplant	6659
@NP	Most of the cells	6671
@NP	Most	6671
@NP	the cells	6679
@NP	the site of the injection -LRB- A ; lowpower view of the lesion site -RRB-	6705
@NP	the site	6705
@NP	the injection -LRB- A ; lowpower view of the lesion site -RRB-	6717
@NP	the injection	6717
@NP	A ; lowpower view of the lesion site	6732
@NP	A	6732
@NP	lowpower view of the lesion site	6735
@NP	lowpower view	6735
@NP	the lesion site	6752
@NP	the expression of T-SV40 in vivo	6782
@NP	the expression	6782
@NP	T-SV40 in vivo	6800
@NP	T-SV40	6800
@NP	vivo	6810
@NP	the number of BrdU-positive nuclei in B with the number of T-SV40	6824
@NP	the number	6824
@NP	BrdU-positive nuclei in B with the number of T-SV40	6838
@NP	BrdU-positive nuclei	6838
@NP	B with the number of T-SV40	6862
@NP	B	6862
@NP	the number of T-SV40	6869
@NP	the number	6869
@NP	T-SV40	6883
@NP	positive nuclei in C	6891
@NP	positive nuclei	6891
@NP	C	6910
@NP	Quantification	6918
@NP	the number of TEG3 cells in the spinal cord of animals sacrificed at 2	6936
@NP	the number	6936
@NP	TEG3 cells in the spinal cord of animals sacrificed at 2	6950
@NP	TEG3 cells	6950
@NP	the spinal cord of animals sacrificed at 2	6964
@NP	the spinal cord	6964
@NP	animals sacrificed at 2	6983
@NP	animals	6983
@NP	2	7005
@NP	n	7008
@NP	4	7012
@NP	4 -LRB- n = 3 -RRB-	7016
@NP	4	7016
@NP	n	7019
@NP	3	7023
@NP	10 -LRB- n = 3 -RRB- weeks posttransplantation	7031
@NP	10	7031
@NP	n	7035
@NP	3	7039
@NP	weeks posttransplantation	7042
@NP	Means ± SEM of the number of BrdU-positive nuclei/field	7069
@NP	Means ± SEM	7069
@NP	the number of BrdU-positive nuclei/field	7084
@NP	the number	7084
@NP	BrdU-positive nuclei/field	7098
@NP	original magnification x250	7126
@NP	the ordinate versus the time of sacrifice	7174
@NP	the ordinate	7174
@NP	the time of sacrifice	7194
@NP	the time	7194
@NP	sacrifice	7206
@NP	the abscissa	7219
@NP	*** P b 0.005 , ANOVA and Tukey post hoc test .	7233
@NP	*** P b	7233
@NP	0.005 , ANOVA and Tukey post	7240
@NP	0.005	7240
@NP	ANOVA	7247
@NP	Tukey post	7257
@NP	hoc test	7268
@NP	hoc	7268
@NP	test	7272
@NP	Bars : 100 µm , in the insets 50 µm .	7278
@NP	Bars	7278
@NP	100 µm	7284
@NP	the insets 50 µm	7295
@NP	the insets	7295
@NP	50 µm	7306
@NP	FIG. 3 .	7314
@NP	FIG.	7314
@NP	3	7319
@NP	Spinal cord sagittal sections	7322
@NP	the fate of TEG3 cells	7360
@NP	the fate	7360
@NP	TEG3 cells	7372
@NP	transplant	7389
@NP	the lesioned spinal cord	7405
@NP	TEG3 cells	7431
@NP	BrdU	7460
@NP	transplantation	7474
@NP	-LRB- A , C -- F -RRB- Double immunostaining	7491
@NP	A , C -- F	7492
@NP	A	7492
@NP	C -- F	7495
@NP	C	7495
@NP	F	7497
@NP	BrdU	7526
@NP	3-phosphoglycerate dehydrogenase	7543
@NP	PGDH , red	7577
@NP	PGDH	7577
@NP	red	7583
@NP	-LRB- B -RRB-	7589
@NP	Double immunostaining	7593
@NP	BrdU -LRB- green -RRB- and glial fibrillary acidic protein -LRB- red -RRB-	7619
@NP	BrdU	7619
@NP	glial fibrillary acidic protein	7636
@NP	red	7669
@NP	Animals	7675
@NP	with TEG3 -LRB- A -- C , E , and F -RRB-	7696
@NP	with TEG3	7696
@NP	A -- C , E , and F	7707
@NP	C , E , and F	7709
@NP	C	7709
@NP	E	7712
@NP	F	7719
@NP	vehicle only	7747
@NP	DMEM	7761
@NP	D	7767
@NP	4 -LRB- A , B ; standard fluorescence microscopy -RRB-	7789
@NP	4	7789
@NP	A , B ; standard fluorescence microscopy	7792
@NP	A	7792
@NP	B ; standard fluorescence microscopy	7795
@NP	B	7795
@NP	standard fluorescence microscopy	7798
@NP	10 weeks -LRB- C -- F ; confocal microscopy -RRB- postinjury / transplant	7836
@NP	10 weeks -LRB- C -- F ; confocal microscopy -RRB- postinjury	7836
@NP	10 weeks -LRB- C -- F ; confocal microscopy -RRB-	7836
@NP	C	7846
@NP	F ; confocal microscopy	7848
@NP	F	7848
@NP	confocal microscopy	7851
@NP	transplant	7884
@NP	the nuclear BrdU -LRB- green -RRB-	7901
@NP	the nuclear BrdU	7901
@NP	cytoplasmic PGDH -LRB- red -RRB-	7930
@NP	cytoplasmic PGDH	7930
@NP	red	7948
@NP	immunostaining	7953
@NP	TEG3 cells after 4 -LRB- A -RRB- and 10 -LRB- C -RRB-	7971
@NP	TEG3 cells	7971
@NP	4 -LRB- A -RRB- and 10 -LRB- C -RRB-	7988
@NP	4 -LRB- A -RRB-	7988
@NP	10 -LRB- C -RRB-	7998
@NP	weeks in vivo	8005
@NP	weeks	8005
@NP	vivo	8014
@NP	the capacity of TEG3 cells	8023
@NP	the capacity	8023
@NP	TEG3 cells	8039
@NP	Schwann cell-like , astrocyte-like	8061
@NP	Schwann	8061
@NP	arrowheads and asterisks , respectively , in C , E , and F	8096
@NP	arrowheads and asterisks , respectively ,	8096
@NP	arrowheads and asterisks	8096
@NP	C , E , and F	8139
@NP	C	8139
@NP	E	8142
@NP	F	8149
@NP	intermediate morphologies -LRB- stars and arrows in C and E -RRB- in vivo	8157
@NP	intermediate morphologies -LRB- stars and arrows in C and E -RRB-	8157
@NP	intermediate morphologies	8157
@NP	stars and arrows in C and E	8184
@NP	stars and arrows	8184
@NP	C and E	8204
@NP	vivo	8216
@NP	TEG3 cells -LRB- BrdU-positive green nuclei in B -RRB-	8222
@NP	TEG3 cells	8222
@NP	BrdU-positive green nuclei in B	8234
@NP	BrdU-positive green nuclei	8234
@NP	B	8264
@NP	reactive astrocytes	8285
@NP	red processes in B	8306
@NP	red processes	8306
@NP	B	8323
@NP	Autofluorescence of debris in the lesion site	8327
@NP	Autofluorescence	8327
@NP	debris in the lesion site	8347
@NP	debris	8347
@NP	the lesion site	8357
@NP	B	8392
@NP	Bar in A -LRB- as for B -RRB-	8396
@NP	Bar	8396
@NP	A -LRB- as for B -RRB-	8403
@NP	A	8403
@NP	B	8413
@NP	25 µm ; in C and F -LRB- as for E -RRB- , 30 µm ; and in D , 45 µm	8417
@NP	25 µm	8417
@NP	C and F -LRB- as for E -RRB- , 30 µm	8427
@NP	C and F -LRB- as for E -RRB-	8427
@NP	C and F	8427
@NP	E	8443
@NP	30 µm	8447
@NP	D	8461
@NP	45 µm	8464
@NP	FIG. 4 .	8472
@NP	FIG.	8472
@NP	4	8477
@NP	Ascending regenerating axons of the sensory tracts	8480
@NP	Ascending regenerating axons	8480
@NP	the sensory tracts	8512
@NP	TEG3	8543
@NP	the spinal cord	8551
@NP	dorsal column crush	8573
@NP	The left median and sciatic nerves	8594
@NP	The left median	8594
@NP	sciatic nerves	8614
@NP	injection of cholera toxin B-subunit -LRB- CTB -RRB-	8645
@NP	injection	8645
@NP	cholera toxin B-subunit -LRB- CTB -RRB-	8658
@NP	cholera toxin B-subunit	8658
@NP	CTB	8683
@NP	Immunostaining with anti-CTB	8689
@NP	Immunostaining	8689
@NP	the fasciculi cuneatus and gracilis	8742
@NP	animals	8781
@NP	A -- E	8790
@NP	A	8790
@NP	E	8792
@NP	TEG3 and -LRB- F and G -RRB- mock-transplanted	8813
@NP	TEG3	8813
@NP	F and G	8823
@NP	F	8823
@NP	G	8829
@NP	mock-transplanted	8832
@NP	vehicle only -LRB- DMEM -RRB-	8855
@NP	vehicle only	8855
@NP	DMEM	8869
@NP	Animals	8876
@NP	4 -LRB- A -- C -RRB- and 10 -LRB- D -- G -RRB-	8903
@NP	4	8903
@NP	A -- C	8906
@NP	A	8906
@NP	C	8908
@NP	10	8915
@NP	D -- G	8919
@NP	D	8919
@NP	G	8921
@NP	weeks	8924
@NP	lesion / transplant ; -LRB- B and C -RRB-	8936
@NP	lesion / transplant ;	8936
@NP	lesion	8936
@NP	transplant	8944
@NP	B and C	8957
@NP	B	8957
@NP	C	8963
@NP	pictures	8976
@NP	adjacent sagittal sections	8988
@NP	the injured spinal cord of an animal transplanted with TEG3	9018
@NP	the injured spinal cord	9018
@NP	an animal transplanted with TEG3	9045
@NP	an animal transplanted	9045
@NP	TEG3	9073
@NP	B , E , and G	9080
@NP	B	9080
@NP	E	9083
@NP	G	9090
@NP	views	9103
@NP	the squares in -LRB- A , D , and F -RRB- , respectively	9112
@NP	the squares	9112
@NP	in -LRB- A , D , and F -RRB- , respectively	9124
@NP	in -LRB- A , D , and F -RRB-	9124
@NP	in	9124
@NP	A , D , and F	9128
@NP	A	9128
@NP	D	9131
@NP	F	9138
@NP	-LRB- D and F -RRB- dashed	9159
@NP	D and F	9160
@NP	lines	9176
@NP	the limits between lesion site -LRB- asterisk -RRB- and the adjacent territory	9192
@NP	the limits	9192
@NP	lesion site -LRB- asterisk -RRB- and the adjacent territory	9211
@NP	lesion site -LRB- asterisk -RRB-	9211
@NP	lesion site	9211
@NP	asterisk	9224
@NP	the adjacent territory	9238
@NP	Axons	9262
@NP	the lesion area -LRB- A , D , arrowheads in B and E -RRB-	9301
@NP	the lesion area	9301
@NP	A , D	9318
@NP	A	9318
@NP	D	9321
@NP	arrowheads in B and E	9324
@NP	arrowheads	9324
@NP	B and E	9338
@NP	many TEG3 cells -LRB- C -RRB-	9364
@NP	many TEG3 cells	9364
@NP	C	9381
@NP	Growth cone-like endings	9385
@NP	B -LRB- arrowheads -RRB-	9429
@NP	B	9429
@NP	arrowheads	9432
@NP	mock-transplanted rats -LRB- F and G -RRB-	9448
@NP	mock-transplanted rats	9448
@NP	F and G	9472
@NP	F	9472
@NP	G	9478
@NP	few if any CTB-stained fibers	9482
@NP	the lesion area -LRB- asterisk in F -RRB-	9533
@NP	the lesion area	9533
@NP	asterisk in F	9550
@NP	asterisk	9550
@NP	F	9562
@NP	fact	9569
@NP	we	9574
@NP	axons caudal to the lesion site	9583
@NP	axons	9583
@NP	the lesion site	9599
@NP	line in F	9627
@NP	line	9627
@NP	F	9635
@NP	growth cone-like endings	9643
@NP	1808	9676
@NP	the lesioned area -LRB- asterisks in G -RRB-	9699
@NP	the lesioned area	9699
@NP	asterisks in G	9718
@NP	asterisks	9718
@NP	G	9731
@NP	-LRB- A -- C -RRB- Standard microscopy .	9735
@NP	-LRB- A -- C -RRB-	9735
@NP	Standard microscopy	9741
@NP	-LRB- D -- G -RRB-	9762
@NP	D -- G	9763
@NP	D	9763
@NP	G	9765
@NP	microscopy	9777
@NP	Bars : A , 100 µm ; B and C , 25 µm ; D and F , 45 µm ; E and G , 30 µm .	9789
@NP	Bars	9789
@NP	A , 100 µm	9795
@NP	A	9795
@NP	100 µm	9798
@NP	B and C , 25 µm	9806
@NP	B and C	9806
@NP	25 µm	9815
@NP	D and F , 45 µm	9822
@NP	D and F	9822
@NP	45 µm	9831
@NP	E and G , 30 µm	9838
@NP	E and G	9838
@NP	30 µm	9847
@NP	FIG. 5 .	9855
@NP	FIG.	9855
@NP	5	9860
@NP	Descending regenerating axons of the motor corticospinal tract -LRB- CST -RRB-	9863
@NP	Descending regenerating axons	9863
@NP	the motor corticospinal tract -LRB- CST -RRB-	9896
@NP	the motor corticospinal tract	9896
@NP	CST	9927
@NP	TEG3	9944
@NP	the spinal cord	9952
@NP	dorsal column crush	9974
@NP	-LRB- A -- F -RRB- Spinal cord sagittal sections .	9995
@NP	-LRB- A -- F -RRB- Spinal cord sagittal sections	9995
@NP	-LRB- A -- F -RRB- Spinal cord	9995
@NP	A -- F	9996
@NP	A	9996
@NP	F	9998
@NP	sagittal sections	10013
@NP	We	10032
@NP	the CST	10043
@NP	injection of biotinylated dextran amine -LRB- BDA -RRB- into the motor cortex	10054
@NP	injection	10054
@NP	dextran amine -LRB- BDA -RRB-	10080
@NP	dextran amine	10080
@NP	BDA	10095
@NP	the motor cortex	10105
@NP	Immunostaining	10123
@NP	BDA -LRB- green in A -- F -RRB- and BrdU -LRB- red in A and B -RRB-	10142
@NP	BDA	10142
@NP	A -- F	10156
@NP	F	10158
@NP	BrdU	10165
@NP	red in A and B	10171
@NP	red in	10171
@NP	red	10171
@NP	A and B	10178
@NP	-LRB- A and D -RRB- Low-power overview	10197
@NP	A and D	10198
@NP	A	10198
@NP	D	10204
@NP	the lesion site in TEG3 - and mock-transplanted rats	10233
@NP	the lesion site	10233
@NP	TEG3 - and mock-transplanted rats	10252
@NP	10 weeks	10299
@NP	transplant	10314
@NP	Insets	10326
@NP	views of BDA-traced fibers of the CST rostral	10348
@NP	views	10348
@NP	BDA-traced fibers of the CST rostral	10357
@NP	BDA-traced fibers	10357
@NP	the CST rostral	10378
@NP	the lesion site	10397
@NP	-LRB- B and C -RRB-	10414
@NP	B	10415
@NP	C	10421
@NP	views of the left and right squares of -LRB- A -RRB-	10434
@NP	views	10434
@NP	the left and right squares of -LRB- A -RRB-	10443
@NP	the left and right squares of	10443
@NP	the left and right squares	10443
@NP	A	10474
@NP	E and F	10482
@NP	E	10482
@NP	F	10488
@NP	those	10494
@NP	D	10504
@NP	Inset in -LRB- B -RRB-	10508
@NP	Inset in	10508
@NP	Inset	10508
@NP	B	10518
@NP	a higher power view of BDA-traced fibers in the lesion site	10536
@NP	a higher power view	10536
@NP	BDA-traced fibers in the lesion site	10559
@NP	BDA-traced fibers	10559
@NP	the lesion site	10580
@NP	animals	10618
@NP	CST sprouting	10645
@NP	CST	10645
@NP	growth cone tips	10663
@NP	BDA-stained axons	10683
@NP	green , arrowheads in B and inset in B	10702
@NP	green	10702
@NP	arrowheads in B and inset in B	10709
@NP	arrowheads	10709
@NP	B	10723
@NP	B	10738
@NP	TEG3 cells	10760
@NP	red for BrdU	10780
@NP	red	10780
@NP	BrdU	10788
@NP	B	10796
@NP	B	10811
@NP	the lesion site	10817
@NP	Caudal to the lesion -LRB- C -RRB- , numerous BDA-stained fibers	10834
@NP	Caudal	10834
@NP	the lesion -LRB- C -RRB- , numerous BDA-stained fibers	10844
@NP	the lesion -LRB- C -RRB-	10844
@NP	the lesion	10844
@NP	C	10856
@NP	numerous BDA-stained fibers	10860
@NP	the lesion site	10924
@NP	a representative mock-transplanted animal -LRB- D -RRB-	10944
@NP	a representative mock-transplanted animal	10944
@NP	D	10987
@NP	we	10991
@NP	BDA-stained fibers	11004
@NP	the lesion site -LRB- D , closer view of the left square in E -RRB-	11035
@NP	the lesion site	11035
@NP	D , closer view of the left square in E	11052
@NP	D	11052
@NP	closer view of the left square in E	11055
@NP	closer view	11055
@NP	the left square in E	11070
@NP	the left square	11070
@NP	E	11089
@NP	no labeled fibers -LRB- D , closer view of the right square in F -RRB-	11102
@NP	no labeled fibers	11102
@NP	D , closer view of the right square in F	11121
@NP	D	11121
@NP	closer view of the right square in F	11124
@NP	closer view	11124
@NP	the right square in F	11139
@NP	the right square	11139
@NP	F	11159
@NP	the lesion site	11179
@NP	the graph -LRB- bottom right -RRB-	11199
@NP	the graph	11199
@NP	bottom right	11210
@NP	the quantification of the number of BDA-labeled axons in TEG3	11225
@NP	the quantification	11225
@NP	the number of BDA-labeled axons in TEG3	11247
@NP	the number	11247
@NP	BDA-labeled axons in TEG3	11261
@NP	BDA-labeled axons	11261
@NP	TEG3	11282
@NP	mocktransplanted animals	11292
@NP	means	11318
@NP	SEM , n = 3 each group	11326
@NP	SEM	11326
@NP	n = 3 each group	11331
@NP	n	11331
@NP	= 3 each group	11333
@NP	3	11335
@NP	the distance from the lesion	11356
@NP	the distance	11356
@NP	the lesion	11374
@NP	1 unit	11395
@NP	distance = 500 µm	11405
@NP	distance	11405
@NP	= 500 µm	11414
@NP	500	11416
@NP	point 0	11424
@NP	the center of the lesion site	11435
@NP	the center	11435
@NP	the lesion site	11449
@NP	negative and positive numbers	11466
@NP	areas rostral and caudal	11506
@NP	areas	11506
@NP	the lesion site	11534
@NP	P	11566
@NP	0.05	11570
@NP	P	11581
@NP	0.01 -LRB- ANOVA and Tukey post hoc test -RRB-	11585
@NP	0.01	11585
@NP	ANOVA and Tukey post hoc test	11591
@NP	ANOVA and Tukey post hoc	11591
@NP	ANOVA and Tukey	11591
@NP	test	11616
@NP	total ablation of the CST caudal	11633
@NP	total ablation	11633
@NP	the CST caudal	11651
@NP	the lesion site	11669
@NP	we	11686
@NP	immunostaining	11699
@NP	PKC-gamma -LRB- a marker of CST -RRB-	11718
@NP	PKC-gamma	11718
@NP	a marker of CST	11729
@NP	a marker	11729
@NP	CST	11741
@NP	transverse sections of the lumbar spinal cord in control	11749
@NP	transverse sections	11749
@NP	the lumbar spinal cord in control	11772
@NP	the lumbar spinal cord	11772
@NP	control	11798
@NP	animals -LRB- 10 weeks after lesion/transplant -RRB-	11819
@NP	animals	11819
@NP	10 weeks after lesion/transplant	11828
@NP	10 weeks	11828
@NP	lesion/transplant	11843
@NP	PKC-gamma immunoreactivity	11867
@NP	the dorsal horn and CST	11897
@NP	arrowhead	11922
@NP	control lumbar spinal cord	11936
@NP	H	11965
@NP	all lesioned animals	11971
@NP	CST PKC-g immunoreactivity	11992
@NP	the lumbar level -LRB- arrowhead -RRB-	12034
@NP	the lumbar level	12034
@NP	arrowhead	12052
@NP	Bars : A , inset in A , C , and D , 100 µm ;	12064
@NP	Bars	12064
@NP	A , inset in A , C , and D , 100 µm	12070
@NP	A , C ,	12082
@NP	C	12085
@NP	D , 100 µm	12092
@NP	D	12092
@NP	100 µm	12095
@NP	B , inset in B , and E -LRB- as for F -RRB- , 45 µm	12103
@NP	B , inset in B	12103
@NP	B	12103
@NP	B	12115
@NP	E -LRB- as for F -RRB- , 45 µm	12122
@NP	E	12122
@NP	F	12132
@NP	45 µm	12136
@NP	G -LRB- as for H -RRB- , 200 µm	12143
@NP	G	12143
@NP	H	12153
@NP	200 µm	12157
@NP	FIG. 6 .	12166
@NP	FIG.	12166
@NP	6	12171
@NP	Functional recovery	12174
@NP	TEG3 cells	12215
@NP	the injured spinal cord	12231
@NP	The animals	12256
@NP	6 unoperated , 6 mock-transplanted with DMEM , and 6 TEG3-treated rats	12269
@NP	6 unoperated	12269
@NP	6	12269
@NP	6 mock-transplanted with DMEM	12283
@NP	6	12283
@NP	DMEM	12308
@NP	6 TEG3-treated rats	12318
@NP	10 weeks for histological analysis	12382
@NP	10 weeks	12382
@NP	histological analysis	12395
@NP	A and B	12419
@NP	A	12419
@NP	B	12425
@NP	the tape removal task	12431
@NP	lesioned rats mock transplanted with vehicle	12454
@NP	lesioned rats mock	12454
@NP	lesioned rats	12454
@NP	mock	12468
@NP	vehicle	12491
@NP	unlesioned control rats	12534
@NP	their ability both to sense and subsequently to remove the adhesive tape	12562
@NP	their ability	12562
@NP	sense and subsequently to remove the adhesive tape	12584
@NP	sense	12584
@NP	the adhesive tape	12617
@NP	significantly higher latency scores throughout the testing period	12641
@NP	significantly higher latency scores	12641
@NP	the testing period	12688
@NP	contrast	12711
@NP	lesioned rats transplanted with TEG3 cells	12721
@NP	lesioned rats	12721
@NP	TEG3 cells	12753
@NP	a moderate functional recovery	12769
@NP	control latencies	12818
@NP	the beam task	12844
@NP	lesioned rats mock transplanted with vehicle	12859
@NP	lesioned rats mock	12859
@NP	lesioned rats	12859
@NP	mock	12873
@NP	vehicle	12896
@NP	significantly more foot-slip errors	12909
@NP	controls	12950
@NP	contrast	12963
@NP	lesioned rats transplanted with TEG3 cells	12973
@NP	lesioned rats	12973
@NP	TEG3 cells	13005
@NP	a marked functional recovery	13025
@NP	this task	13057
@NP	results	13079
@NP	those of the control unoperated group	13126
@NP	those	13126
@NP	the control unoperated group	13135
@NP	Data	13165
@NP	± SEM	13180
@NP	asterisks	13187
@NP	significant difference from unlesioned control rats :	13204
@NP	significant difference	13204
@NP	unlesioned control rats	13232
@NP	P <	13258
@NP	P	13258
@NP	<	13260
@NP	0.05 , ** P < 0.01 , and *** P <	13262
@NP	0.05 , ** P < 0.01 ,	13262
@NP	0.05	13262
@NP	P <	13270
@NP	P	13270
@NP	<	13272
@NP	0.01	13274
@NP	*** P <	13284
@NP	*** P	13284
@NP	0.001 , ANOVA and Tukey post hoc	13291
@NP	0.001 , ANOVA	13291
@NP	0.001	13291
@NP	ANOVA	13298
@NP	Tukey post hoc	13308
@NP	Tukey post	13308
@NP	hoc	13319
@NP	test	13323
@NP	Morphological Aspects	13331
@NP	Primary Immortalized OEG Cells and the Generation of Clonal Lines in Culture	13356
@NP	Primary Immortalized OEG Cells	13356
@NP	the Generation of Clonal Lines in Culture	13391
@NP	the Generation	13391
@NP	Clonal Lines in Culture	13409
@NP	Clonal Lines	13409
@NP	Culture	13425
@NP	We	13433
@NP	20 clonal lines -LRB- TEG1 -- 20 -RRB- of immortalized rat	13459
@NP	20 clonal lines	13459
@NP	TEG1 -- 20	13476
@NP	TEG1	13476
@NP	20	13481
@NP	immortalized rat	13488
@NP	olfactory ensheathing glia	13505
@NP	29,30 -RSB-	13533
@NP	These lines	13541
@NP	simple medium -LRB- M10 -RRB-	13583
@NP	simple medium	13583
@NP	M10	13598
@NP	they	13607
@NP	a variety of different culture conditions -LRB- see Materials and Methods -RRB-	13632
@NP	a variety	13632
@NP	different culture conditions	13645
@NP	Materials and Methods	13679
@NP	Materials	13679
@NP	Methods	13693
@NP	M10 medium	13706
@NP	the majority of TEG3 cells	13718
@NP	the majority	13718
@NP	TEG3 cells	13734
@NP	a flat polygonal morphology	13755
@NP	ME10 and ME3 medium	13795
@NP	the majority of cells	13816
@NP	the majority	13816
@NP	cells	13832
@NP	a bipolar morphology -LRB- Figs. 1A and B , and data not shown	13846
@NP	a bipolar morphology -LRB- Figs. 1A and B	13846
@NP	data not shown	13888
@NP	data	13888
@NP	The cell morphology	13905
@NP	the medium	13977
@NP	TEG3	14016
@NP	different morphological features	14033
@NP	their microenvironment	14079
@NP	These cell phenotypes	14103
@NP	the main types	14158
@NP	olfactory ensheathing glia	14187
@NP	astrocyte-like -LRB- or fibroblastlike -RRB-	14215
@NP	astrocyte-like	14215
@NP	Schwann cell-like -LSB- 5,20,27,31	14254
@NP	Schwann	14254
@NP	-LSB- 5,20,27,31	14272
@NP	34 -RSB-	14284
@NP	The Fate	14289
@NP	TEG3 Cells in Vivo after Transplantation Concomitant with Spinal Cord Injury	14301
@NP	TEG3 Cells	14301
@NP	Vivo after Transplantation Concomitant with Spinal Cord Injury	14315
@NP	Transplantation Concomitant with Spinal Cord	14326
@NP	Transplantation	14326
@NP	Spinal Cord	14359
@NP	the capacity of TEG3 cells	14390
@NP	the capacity	14390
@NP	TEG3 cells	14406
@NP	repair	14428
@NP	the injured CNS in vivo	14438
@NP	the injured CNS	14438
@NP	vivo	14457
@NP	we	14463
@NP	the spinal cord injury model	14476
@NP	bilateral crushing of the rat dorsal columns at spinal level C3 -LSB- 35 -RSB-	14519
@NP	bilateral crushing	14519
@NP	the rat dorsal columns at spinal level C3 -LSB- 35 -RSB-	14541
@NP	the rat dorsal columns	14541
@NP	spinal level C3 -LSB- 35 -RSB-	14567
@NP	spinal level C3	14567
@NP	35 -RSB-	14584
@NP	the lesion	14617
@NP	we	14629
@NP	TEG3 cells	14641
@NP	the animals	14657
@NP	control animals	14686
@NP	the vehicle	14707
@NP	We	14726
@NP	sham-operated and unoperated control animals	14741
@NP	parallel	14789
@NP	The TEG3 cells	14799
@NP	immunostaining for SV40 large T antigen -LRB- T-SV40 -RRB-	14843
@NP	immunostaining	14843
@NP	SV40 large T antigen	14862
@NP	T-SV40	14884
@NP	One week	14893
@NP	spinal cord injury and transplantation	14908
@NP	spinal cord injury	14908
@NP	transplantation	14931
@NP	we	14948
@NP	nuclear expression of TSV40	14960
@NP	nuclear expression	14960
@NP	TSV40	14982
@NP	numerous TEG3 cells readily distinguishable	14991
@NP	numerous TEG3 cells	14991
@NP	the region of the spinal cord -LRB- Supplementary Figs	15038
@NP	the region	15038
@NP	the spinal cord -LRB- Supplementary Figs	15052
@NP	cord -LRB- Supplementary Figs	15063
@NP	cord	15063
@NP	Supplementary Figs	15069
@NP	Supplementary	15069
@NP	Figs	15083
@NP	A and B -RRB- .	15089
@NP	A and B	15089
@NP	The number of cells expressing T-SV40	15099
@NP	The number	15099
@NP	cells expressing T-SV40	15113
@NP	cells	15113
@NP	T-SV40	15130
@NP	2 weeks after injury -LRB- Supplementary Figs	15151
@NP	2 weeks	15151
@NP	2	15151
@NP	weeks	15153
@NP	injury -LRB- Supplementary Figs	15165
@NP	injury	15165
@NP	Supplementary Figs	15173
@NP	Supplementary	15173
@NP	Figs	15187
@NP	C and D -RRB- and by 4 weeks virtually no cells expressing the T-SV40	15193
@NP	C and D -RRB- and by 4 weeks virtually no cells	15193
@NP	C and D -RRB-	15193
@NP	C	15193
@NP	D	15199
@NP	by 4 weeks virtually no cells	15206
@NP	4 weeks	15209
@NP	virtually no cells	15217
@NP	the T-SV40	15247
@NP	Fig. 2C	15281
@NP	this loss of T-SV40 expression	15302
@NP	this loss	15302
@NP	T-SV40 expression	15315
@NP	silencing of the gene rather than the loss of TEG3 cells	15344
@NP	silencing of the gene	15344
@NP	silencing	15344
@NP	the gene	15357
@NP	the loss of TEG3 cells	15378
@NP	the loss	15378
@NP	TEG3 cells	15390
@NP	we	15407
@NP	the TEG3 cells	15418
@NP	5-bromo-3-deoxyuridine -LRB- BrdU -RRB- 1 day	15438
@NP	5-bromo-3-deoxyuridine	15438
@NP	BrdU	15462
@NP	1 day	15468
@NP	transplantation	15481
@NP	we	15498
@NP	the viability of the TEG3 cells	15512
@NP	the viability	15512
@NP	the TEG3 cells	15529
@NP	90 %	15560
@NP	2 and 4 weeks after injury / transplant TEG3 cells	15573
@NP	2 and 4 weeks	15573
@NP	injury / transplant TEG3 cells	15593
@NP	injury	15593
@NP	transplant TEG3 cells	15601
@NP	anti- BrdU immunostaining -LRB- Supplementary Fig	15652
@NP	anti- BrdU	15652
@NP	immunostaining -LRB- Supplementary Fig	15663
@NP	immunostaining	15663
@NP	Supplementary Fig	15679
@NP	Supplementary	15679
@NP	Fig	15693
@NP	C and Fig. 2A -RRB-	15698
@NP	C	15698
@NP	Fig. 2A	15704
@NP	T-SV40 expression in many of these BrdU cells	15720
@NP	T-SV40 expression	15720
@NP	many of these BrdU cells	15741
@NP	many	15741
@NP	these BrdU cells	15749
@NP	these time points	15786
@NP	Supplementary Figs	15813
@NP	C and D and Figs. 2B and 2C -RRB- .	15833
@NP	C and D and Figs. 2B and 2C -RRB-	15833
@NP	C and D	15833
@NP	Figs. 2B and 2C -RRB-	15845
@NP	Figs. 2B	15845
@NP	2C	15858
@NP	We	15863
@NP	this phenomenon	15874
@NP	the number of BrdU-labeled cells	15913
@NP	the number	15913
@NP	BrdU-labeled cells	15927
@NP	the injury site at different times	15953
@NP	the injury site	15953
@NP	different times	15972
@NP	injection -LRB- 2 , 4 , 10 weeks -RRB-	15994
@NP	injection	15994
@NP	2	16005
@NP	4	16008
@NP	10 weeks	16011
@NP	at least three different sagittal sections	16028
@NP	the injured spinal cord at the center of the lesion	16074
@NP	the injured spinal cord	16074
@NP	the center of the lesion	16101
@NP	the center	16101
@NP	the lesion	16115
@NP	2 weeks	16133
@NP	injection	16147
@NP	we	16157
@NP	685 ± 65 nuclei/field -LRB- x250 ; n = 4 -RRB-	16164
@NP	685 ± 65 nuclei/field	16164
@NP	685 ±	16164
@NP	65 nuclei/field	16170
@NP	x250 ; n = 4	16187
@NP	x250	16187
@NP	n = 4	16193
@NP	n	16193
@NP	4	16197
@NP	this number	16201
@NP	299 ±	16224
@NP	35 and 262 ± 33 nuclei/field	16230
@NP	4 -LRB- n = 3 -RRB- and 10 -LRB- n = 3 -RRB- weeks , respectively	16265
@NP	4	16265
@NP	n	16268
@NP	3	16272
@NP	10 -LRB- n = 3 -RRB- weeks	16279
@NP	10	16279
@NP	n	16283
@NP	3	16287
@NP	weeks	16290
@NP	± SEM ; P < 0.005 ; comparison with the number of nuclei /	16316
@NP	± SEM	16316
@NP	P < 0.005 ; comparison with the number of nuclei	16323
@NP	P	16323
@NP	< 0.005 ; comparison with the number of nuclei	16325
@NP	< 0.005	16325
@NP	<	16325
@NP	0.005	16327
@NP	comparison with the number of nuclei	16334
@NP	comparison	16334
@NP	the number of nuclei	16350
@NP	the number	16350
@NP	nuclei	16364
@NP	field at 4 and 10 weeks vs 2 weeks	16372
@NP	field	16372
@NP	4 and 10 weeks vs 2 weeks	16381
@NP	4 and 10 weeks	16381
@NP	2 weeks	16399
@NP	We	16409
@NP	no significant differences between the numbers of nuclei	16421
@NP	no significant differences	16421
@NP	the numbers of nuclei	16456
@NP	the numbers	16456
@NP	nuclei	16471
@NP	field	16479
@NP	4 and 10 weeks -LRB- P > 0.05 ; ANOVA and post hoc Tukey test , Fig. 2D -RRB-	16488
@NP	4 and 10 weeks	16488
@NP	P > 0.05 ; ANOVA and post hoc Tukey test , Fig. 2D	16504
@NP	P	16504
@NP	> 0.05 ; ANOVA and post hoc Tukey test , Fig. 2D	16506
@NP	> 0.05	16506
@NP	>	16506
@NP	0.05	16508
@NP	ANOVA and post hoc Tukey test , Fig. 2D	16514
@NP	ANOVA	16514
@NP	post hoc Tukey test , Fig. 2D	16524
@NP	hoc Tukey test , Fig.	16529
@NP	hoc Tukey test	16529
@NP	Fig.	16545
@NP	approximately 40 % of the cells present 2 weeks after transplantation	16561
@NP	approximately 40 %	16561
@NP	the cells present 2 weeks after transplantation	16582
@NP	the cells	16582
@NP	2 weeks	16600
@NP	transplantation	16614
@NP	the center of the damaged area	16642
@NP	the center	16642
@NP	the damaged area	16656
@NP	4 and 10 weeks	16679
@NP	The transplanted cells that remained around the area of the lesion	16695
@NP	The transplanted cells	16695
@NP	the area of the lesion	16739
@NP	the area	16739
@NP	the lesion	16751
@NP	the dorsoventral axis in some animals	16783
@NP	the dorsoventral axis	16783
@NP	some animals	16808
@NP	we	16831
@NP	TEG3 cells	16850
@NP	segments of the spinal cord caudal or rostral	16864
@NP	segments	16864
@NP	the spinal cord caudal or rostral	16876
@NP	the spinal cord caudal	16876
@NP	rostral	16902
@NP	the lesioned area	16913
@NP	The grafted TEG3 cells	16932
@NP	cytoplasmic expression	16970
@NP	the OEG marker 3-phosphoglycerate dehydrogenase	16996
@NP	the OEG marker	16996
@NP	3-phosphoglycerate dehydrogenase	17011
@NP	PGDH ; Figs. 3A and 3C	17045
@NP	PGDH	17045
@NP	Figs. 3A and 3C	17051
@NP	in vivo and in culture	17074
@NP	Fig. 1	17102
@NP	The cells that integrated in the spinal cord territory	17111
@NP	The cells	17111
@NP	the spinal cord territory	17140
@NP	distinguishable astrocyte-like , Schwann cell-like	17170
@NP	astrocyte-like , Schwann	17186
@NP	astrocyte-like	17186
@NP	Schwann	17202
@NP	intermediate morphologies -LRB- Figs. 3C , 3E , and 3F -RRB-	17225
@NP	intermediate morphologies	17225
@NP	Figs. 3C , 3E , and 3F	17252
@NP	Figs. 3C	17252
@NP	3E	17262
@NP	3F	17270
@NP	TEG3 cells	17288
@NP	reactive astrocytes in the lesion area -LRB- Fig. 3B -RRB-	17329
@NP	reactive astrocytes	17329
@NP	the lesion area -LRB- Fig. 3B -RRB-	17352
@NP	the lesion area	17352
@NP	Fig. 3B	17369
@NP	we	17385
@NP	the oncogene T-SV40	17397
@NP	the OEG cells	17432
@NP	it	17447
@NP	their tumorigenic potential	17480
@NP	10 weeks , the longest time point that we examined	17523
@NP	10 weeks	17523
@NP	the longest time point that we examined	17533
@NP	the longest time point	17533
@NP	we	17561
@NP	we	17574
@NP	no spinal cord tumors in any of the animals	17586
@NP	no spinal cord tumors	17586
@NP	any of the animals	17611
@NP	any	17611
@NP	the animals	17618
@NP	TEG3 cells	17643
@NP	Figs. 2 and 3	17659
@NP	Figs. 2	17659
@NP	3	17671
@NP	Capacity	17675
@NP	TEG3 Cells	17687
@NP	Repair	17709
@NP	the Injured Spinal Cord Anatomical analysis of TEG3-induced axonal repair	17719
@NP	the	17719
@NP	Spinal Cord Anatomical analysis of TEG3-induced axonal repair	17731
@NP	Spinal Cord Anatomical analysis	17731
@NP	TEG3-induced axonal repair	17766
@NP	We	17794
@NP	the repair	17806
@NP	sensory axons	17830
@NP	the major forelimb and hind-limb nerves , the median and sciatic nerves	17856
@NP	the major forelimb	17856
@NP	hind-limb nerves , the median and sciatic nerves	17879
@NP	hind-limb nerves	17879
@NP	the median	17897
@NP	sciatic nerves	17912
@NP	cholera toxin B-subunit -LRB- CTB -RRB-	17933
@NP	cholera toxin B-subunit	17933
@NP	CTB	17958
@NP	This CTB	17964
@NP	the axons of myelinated sensory neurons	17994
@NP	the axons	17994
@NP	myelinated sensory neurons	18007
@NP	projection neurons in the dorsal columns labeling central axons and terminals	18045
@NP	projection neurons	18045
@NP	the dorsal columns labeling central axons and terminals	18067
@NP	the dorsal columns	18067
@NP	central axons and terminals	18095
@NP	immunostaining with antibodies against CTB	18131
@NP	immunostaining	18131
@NP	antibodies against CTB	18151
@NP	antibodies	18151
@NP	CTB	18170
@NP	the sensory fasciculi cuneatus and gracilis	18183
@NP	the ascending projections	18245
@NP	sensory neurons corresponding to the median and sciatic nerves , respectively	18274
@NP	sensory neurons	18274
@NP	the median and sciatic nerves	18307
@NP	the median	18307
@NP	sciatic nerves	18322
@NP	CTB-labeled axons	18352
@NP	both the fasciculi cuneatus and the gracilis	18375
@NP	the fasciculi cuneatus	18380
@NP	the gracilis	18407
@NP	growth cone-like endings at their tips	18426
@NP	growth cone-like endings	18426
@NP	their tips	18454
@NP	the lesion site where TEG3 cells were present at 2 -LRB- not shown -RRB-	18507
@NP	the lesion site where TEG3 cells were present at 2	18507
@NP	the lesion site	18507
@NP	TEG3 cells	18529
@NP	2	18556
@NP	4 weeks after transplantation -LRB- Figs. 4A , 4B , and 4C -RRB-	18574
@NP	4 weeks	18574
@NP	transplantation -LRB- Figs. 4A , 4B , and 4C -RRB-	18588
@NP	transplantation	18588
@NP	Figs. 4A , 4B , and 4C	18605
@NP	Figs. 4A	18605
@NP	4B	18615
@NP	4C	18623
@NP	10 weeks	18631
@NP	transplantation	18646
@NP	axons	18670
@NP	the lesion	18699
@NP	animals	18713
@NP	TEG3 cells -LRB- 0.5 -- 1 mm ; Figs. 4D and 4E -RRB- , in stark contrast	18739
@NP	TEG3 cells	18739
@NP	0.5	18751
@NP	1 mm ; Figs. 4D and 4E	18755
@NP	1 mm	18755
@NP	Figs. 4D and 4E	18761
@NP	stark contrast	18782
@NP	animals mock-transplanted with the vehicle alone -LRB- DMEM ; Fig. 4F -RRB-	18800
@NP	animals mock-transplanted with the vehicle alone	18800
@NP	animals	18800
@NP	the vehicle	18831
@NP	DMEM ; Fig. 4F	18850
@NP	DMEM	18850
@NP	Fig. 4F	18856
@NP	these animals	18882
@NP	axons	18896
@NP	the lesion site -LRB- Figs. 4F and 4G -RRB-	18931
@NP	the lesion site	18931
@NP	Figs. 4F and 4G	18948
@NP	Figs. 4F	18948
@NP	4G	18961
@NP	our results	18972
@NP	TEG3 cells	18998
@NP	the regrowth	19024
@NP	sensory projections	19050
@NP	the spinal cord lesion site	19075
@NP	their navigation	19115
@NP	an environment that is normally highly refractive to axonal growth	19140
@NP	an environment	19140
@NP	axonal growth	19193
@NP	Figs. 4D and 4F	19216
@NP	Figs. 4D	19216
@NP	4F	19229
@NP	TEG3	19234
@NP	these axons	19270
@NP	the lesion level and	19285
@NP	neuronal death	19318
@NP	We	19334
@NP	CTB labeled axons progress beyond the lesion	19353
@NP	CTB	19353
@NP	axons	19365
@NP	the lesion	19387
@NP	We	19399
@NP	repair	19420
@NP	the major descending pathway	19430
@NP	the dorsal columns , the corticospinal tract -LRB- CST -RRB-	19462
@NP	the dorsal columns	19462
@NP	the corticospinal tract -LRB- CST -RRB-	19482
@NP	the corticospinal tract	19482
@NP	CST	19507
@NP	a control of the dorsal column crush surgery	19516
@NP	a control	19516
@NP	the dorsal column crush surgery	19529
@NP	we	19562
@NP	the distribution of protein kinase C -LRB- PKC -RRB- - gamma	19573
@NP	the distribution	19573
@NP	protein kinase C -LRB- PKC -RRB- - gamma	19593
@NP	protein kinase C -LRB- PKC -RRB-	19593
@NP	protein kinase C	19593
@NP	PKC	19611
@NP	gamma	19616
@NP	immunohistochemistry	19625
@NP	the unlesioned lumbar spinal cord	19650
@NP	we	19685
@NP	PKC-gamma immunoreactivity	19697
@NP	a marker of the CST , -LSB- 35 -RSB- and references therein	19725
@NP	a marker	19725
@NP	the CST	19737
@NP	35 -RSB- and references therein	19747
@NP	35 -RSB- and references	19747
@NP	the dorsal columns and lamina II	19778
@NP	the dorsal columns	19778
@NP	lamina II	19801
@NP	Fig. 5G	19812
@NP	none of the lesioned animals in the study	19825
@NP	none	19825
@NP	the lesioned animals in the study	19833
@NP	the lesioned animals	19833
@NP	the study	19857
@NP	PKC-gamma immunostaining	19871
@NP	the CST	19908
@NP	the lumbar level -LRB- Fig. 5H -RRB-	19919
@NP	the lumbar level	19919
@NP	Fig. 5H	19937
@NP	We	19947
@NP	this	19962
@NP	an indication of successful surgery in terms of the lesion	19970
@NP	an indication	19970
@NP	successful surgery in terms of the lesion	19987
@NP	successful surgery	19987
@NP	terms of the lesion	20009
@NP	terms	20009
@NP	the lesion	20018
@NP	the spinal cord	20032
@NP	the complete ablation of the dorsal column tracts	20060
@NP	the complete ablation	20060
@NP	the dorsal column tracts	20085
@NP	the repair of the CST	20121
@NP	the repair	20121
@NP	the CST	20135
@NP	we	20144
@NP	dextran amine -LRB- BDA -RRB-	20169
@NP	dextran amine	20169
@NP	BDA	20184
@NP	the motor cortex	20194
@NP	unlesioned animals	20215
@NP	we	20235
@NP	a fiber bundle	20247
@NP	the cervical spinal cord	20265
@NP	dorsal column injury	20305
@NP	we	20327
@NP	CST axons	20340
@NP	the spinal cord rostral	20353
@NP	the lesion site -LRB- insets in Figs. 5A and 5D -RRB-	20380
@NP	the lesion site	20380
@NP	insets in Figs. 5A and 5D	20397
@NP	insets	20397
@NP	Figs. 5A and 5D	20407
@NP	Figs. 5A	20407
@NP	5D	20420
@NP	they	20434
@NP	the lesion	20458
@NP	no fibers	20473
@NP	the lesion	20512
@NP	35 -RSB- and references	20525
@NP	5	20572
@NP	animals sacrificed 2 and 4 weeks postinjury / transplantation	20579
@NP	animals	20579
@NP	2 and 4 weeks postinjury / transplantation	20598
@NP	2 and 4 weeks	20598
@NP	transplantation	20624
@NP	we	20641
@NP	a few growth	20654
@NP	conelike endings	20667
@NP	tips of the CST axons at the level of the lesion -LRB- data not shown -RRB-	20687
@NP	tips	20687
@NP	the CST axons	20695
@NP	the level	20712
@NP	the lesion	20725
@NP	data not shown	20737
@NP	data	20737
@NP	rats sacrificed 10 weeks after injury/transplant the CST	20767
@NP	rats	20767
@NP	10 weeks	20783
@NP	the CST	20816
@NP	higher molecular weight BDA -LRB- 10 kDa -RRB-	20841
@NP	higher molecular weight BDA	20841
@NP	10 kDa	20870
@NP	this tract	20906
@NP	TEG3-transplanted animals	20921
@NP	we	20947
@NP	numerous BDA-labeled-fibers rostral	20956
@NP	the lesion site	21006
@NP	20 ±	21023
@NP	1.1 and 21 ± 2.2 , respectively ; Fig. 5 graph	21028
@NP	1.1 and 21 ± 2.2 , respectively	21028
@NP	1.1 and 21	21028
@NP	± 2.2	21039
@NP	Fig. 5 graph	21060
@NP	Fig.	21060
@NP	5 graph	21065
@NP	growth cones	21099
@NP	the tips of the fibers navigating into the lesion site between TEG3 cells	21115
@NP	the tips	21115
@NP	the fibers navigating into the lesion site between TEG3 cells	21127
@NP	the fibers	21127
@NP	the lesion site between TEG3 cells	21154
@NP	the lesion site	21154
@NP	TEG3 cells	21178
@NP	we	21190
@NP	Figs. 5A and 5B	21213
@NP	Figs. 5A	21213
@NP	5B	21226
@NP	the caudal part of the lesion	21234
@NP	the caudal part	21234
@NP	the lesion	21253
@NP	abundant CST fibers	21265
@NP	the lesion site	21304
@NP	20.5 ± 5.5 , graph in Fig. 5 ; Figs. 5A and 5C	21321
@NP	20.5 ± 5.5	21321
@NP	20.5 ±	21321
@NP	5.5	21328
@NP	graph in Fig. 5 ; Figs. 5A	21333
@NP	graph in Fig. 5	21333
@NP	graph	21333
@NP	Fig. 5	21342
@NP	Figs. 5A	21350
@NP	Figs.	21350
@NP	5A	21356
@NP	5C	21363
@NP	no TEG3 cells	21372
@NP	this level -LRB- Figs. 5A and 5C -RRB-	21407
@NP	this level	21407
@NP	Figs. 5A and 5C	21419
@NP	Figs. 5A	21419
@NP	5C	21432
@NP	the mock-transplanted animals	21440
@NP	BDA-labeled fibers	21471
@NP	rostral	21504
@NP	the lesion site	21515
@NP	21 ±	21532
@NP	3.6 ; Figs. 5D and 5E	21537
@NP	3.6	21537
@NP	Figs. 5D and 5E	21542
@NP	some animals	21566
@NP	we	21580
@NP	terminals	21589
@NP	the level of the lesion site	21602
@NP	the level	21602
@NP	the lesion site	21615
@NP	We	21632
@NP	only a few	21639
@NP	fibers , if any , in the lesion site	21658
@NP	fibers , if any ,	21658
@NP	fibers	21658
@NP	the lesion site	21677
@NP	itself	21693
@NP	the lesioned region	21718
@NP	more caudal zones	21744
@NP	the cervical spinal cord	21765
@NP	2 ± 1.9 and 4.3 ± 3.5 , respectively	21791
@NP	2 ± 1.9 and 4.3 ± 3.5	21791
@NP	Figs. 5D	21828
@NP	5F and graph in Fig. 5 ; P < 0.005	21841
@NP	5F and graph in Fig. 5	21841
@NP	5F and graph	21841
@NP	Fig. 5	21857
@NP	P < 0.005	21865
@NP	P <	21865
@NP	P	21865
@NP	0.005	21869
@NP	vs mock-transplanted animals , ANOVA and Tukey post hoc test	21903
@NP	mock-transplanted animals	21906
@NP	ANOVA and Tukey post hoc test	21933
@NP	ANOVA and Tukey	21933
@NP	post hoc test	21949
@NP	These results	21965
@NP	TEG3	21993
@NP	repair of the main descending motor	22010
@NP	repair	22010
@NP	the main descending motor	22020
@NP	tract in the spinal cord	22046
@NP	tract	22046
@NP	the spinal cord	22055
@NP	regrowth of these axons and their navigation	22083
@NP	regrowth	22083
@NP	these axons and their navigation	22095
@NP	these axons	22095
@NP	their navigation	22111
@NP	the lesion site	22147
@NP	The recovery of function	22164
@NP	The recovery	22164
@NP	function	22180
@NP	TEG3	22200
@NP	The dorsal column tracts	22206
@NP	discriminative touch and proprioception	22249
@NP	local spinal reflexes	22308
@NP	skilled motor function	22335
@NP	we	22365
@NP	the sensory and motor function	22377
@NP	the sensory	22377
@NP	motor function	22393
@NP	animals	22411
@NP	TEG3 cells	22437
@NP	two behavioral tests , adhesive tape removal and beam walking	22451
@NP	two behavioral tests	22451
@NP	adhesive tape removal	22473
@NP	beam walking	22499
@NP	We	22513
@NP	the performance	22525
@NP	these transplanted animals	22544
@NP	mock-transplanted and uninjured animals	22576
@NP	35 -RSB- and references	22618
@NP	-LRB- I -RRB-	22647
@NP	the adhesive tape removal test -LRB- see Materials and Methods -RRB-	22654
@NP	the adhesive tape removal test	22654
@NP	Materials and Methods	22690
@NP	Materials	22690
@NP	Methods	22704
@NP	we	22714
@NP	adhesive tape	22724
@NP	the forepaw	22741
@NP	the time	22767
@NP	sense -LRB- sensory ability -RRB-	22785
@NP	sense	22785
@NP	sensory ability	22792
@NP	motor ability	22821
@NP	the tape	22836
@NP	Figs. 6A and 6B	22846
@NP	Figs. 6A	22846
@NP	6B	22859
@NP	Unlesioned control rats	22864
@NP	these tasks	22898
@NP	the performance of mocktransplanted rats	22927
@NP	the performance	22927
@NP	mocktransplanted rats	22946
@NP	P < 0.001 for	22991
@NP	P	22991
@NP	0.001	22995
@NP	tasks , ANOVA and post hoc Tukey test	23010
@NP	tasks	23010
@NP	ANOVA	23017
@NP	post hoc Tukey test	23027
@NP	8 weeks	23052
@NP	the sensory and motor latencies	23071
@NP	3 ± 2 to 43 ± 6 s	23122
@NP	3 ±	23122
@NP	2 to 43 ± 6 s	23124
@NP	2 to 43 ±	23124
@NP	6 s	23132
@NP	11.5	23145
@NP	± 5 to 36 ± 10 s	23150
@NP	unlesioned control animals , respectively -LRB- Fig. 6 -RRB-	23181
@NP	unlesioned control animals , respectively	23181
@NP	unlesioned control animals	23181
@NP	Fig. 6	23223
@NP	TEG3-transplanted animals	23232
@NP	a moderate improvement of function	23268
@NP	a moderate improvement	23268
@NP	function	23294
@NP	the mock-transplanted group	23315
@NP	the sensory and removal aspects	23347
@NP	the test	23382
@NP	P = 0.005 and P = 0.09 , respectively , ANOVA and post hoc Tukey test	23392
@NP	P = 0.005	23392
@NP	P	23392
@NP	0.005	23396
@NP	P = 0.09 , respectively , ANOVA and post hoc Tukey test	23406
@NP	P = 0.09 , respectively	23406
@NP	P	23406
@NP	= 0.09	23408
@NP	ANOVA and post hoc Tukey test	23430
@NP	ANOVA	23430
@NP	post hoc Tukey test	23440
@NP	the values from these animals	23471
@NP	the values	23471
@NP	these animals	23487
@NP	the values	23515
@NP	unlesioned control rats	23529
@NP	P < 0.05 for both tasks of the test , ANOVA and post hoc Tukey test	23554
@NP	P < 0.05 for	23554
@NP	P	23554
@NP	0.05	23558
@NP	tasks of the test , ANOVA and post hoc Tukey test	23572
@NP	tasks	23572
@NP	the test , ANOVA and post hoc Tukey test	23581
@NP	the test	23581
@NP	ANOVA	23591
@NP	post hoc Tukey test	23601
@NP	8 weeks after lesion/transplant	23626
@NP	8 weeks	23626
@NP	lesion/transplant	23640
@NP	the sensory and motor latencies	23659
@NP	25.6 ±	23696
@NP	8 and 24.7 ± 8 s	23703
@NP	TEG3-transplanted animals -LRB- Fig. 6 -RRB-	23724
@NP	TEG3-transplanted animals	23724
@NP	Fig. 6	23751
@NP	These results	23760
@NP	TEG3 treatment	23789
@NP	a significant recovery of performance	23816
@NP	a significant recovery	23816
@NP	performance	23842
@NP	this mixed sensory and motor task	23857
@NP	II	23893
@NP	the beam	23900
@NP	test -LRB- Fig. 6C and see supplementary video data -RRB-	23917
@NP	test	23917
@NP	Fig. 6C and see supplementary video data	23923
@NP	Fig. 6C	23923
@NP	supplementary video data	23939
@NP	the unlesioned control animals	23972
@NP	few foot	24008
@NP	the performance of mock-transplanted rats -LRB- lesion + vehicle -RRB-	24024
@NP	the performance	24024
@NP	mock-transplanted rats -LRB- lesion + vehicle -RRB-	24043
@NP	mock-transplanted rats	24043
@NP	lesion + vehicle	24067
@NP	lesion	24067
@NP	vehicle	24076
@NP	this test -LRB- P = 0.004 , ANOVA and post hoc Tukey test -RRB-	24104
@NP	this test	24104
@NP	P = 0.004 , ANOVA and post	24115
@NP	P	24115
@NP	0.004	24119
@NP	ANOVA	24126
@NP	hoc Tukey test	24141
@NP	8 weeks after lesion	24161
@NP	8 weeks	24161
@NP	lesion	24175
@NP	the incidence of foot	24182
@NP	the incidence	24182
@NP	foot	24199
@NP	0.8 ± 0.3	24229
@NP	28 ± 4	24242
@NP	unlesioned controls	24262
@NP	TEG3 transplantation	24292
@NP	a marked recovery of function	24322
@NP	a marked recovery	24322
@NP	function	24343
@NP	the first week	24357
@NP	the performance of these rats	24384
@NP	the performance	24384
@NP	these rats	24403
@NP	a level	24423
@NP	that	24464
@NP	unoperated controls	24472
@NP	P	24493
@NP	0.05	24497
@NP	ANOVA	24503
@NP	hoc Tukey test ; 8 weeks after lesion/transplant the number of foot slips	24518
@NP	hoc Tukey test	24518
@NP	8 weeks after lesion/transplant the number of foot slips	24534
@NP	8 weeks	24534
@NP	the number of foot	24566
@NP	the number	24566
@NP	foot	24580
@NP	2.8 ± 1	24595
@NP	the TEG3-transplanted group	24606
@NP	our results	24642
@NP	TEG3 cells	24682
@NP	a near-complete recovery of function	24702
@NP	a near-complete recovery	24702
@NP	function	24730
@NP	this type of motor task	24756
@NP	this type	24756
@NP	motor task	24769
@NP	DISCUSSION Transplantation of OEG	24782
@NP	DISCUSSION Transplantation	24782
@NP	OEG	24812
@NP	a valid strategy to recover spinal cord function after injury	24844
@NP	spinal cord function	24872
@NP	injury	24899
@NP	OEG lines	24920
@NP	a feasible alternative to primary OEG	24941
@NP	a feasible alternative	24941
@NP	primary OEG	24967
@NP	Several such lines	24980
@NP	26 -- 30,36 -RSB-	25040
@NP	26	25040
@NP	30,36 -RSB-	25043
@NP	we	25057
@NP	the novel finding	25075
@NP	a homogeneous clonal cell line , derived from a single cell ,	25098
@NP	a homogeneous clonal cell line	25098
@NP	a single cell	25143
@NP	morphological plasticity	25167
@NP	culture	25200
@NP	long-term survival and integration	25232
@NP	the spinal cord -LRB- without forming tumors -RRB-	25272
@NP	the spinal cord	25272
@NP	tumors	25305
@NP	axonal repair and functional recovery	25327
@NP	repair	25334
@NP	spinal cord injury	25371
@NP	any other accompanying cell	25406
@NP	TEG3	25435
@NP	an exception	25447
@NP	we	25461
@NP	several other clonal lines	25483
@NP	primary OEG	25524
@NP	axonal regeneration of mature neurons	25549
@NP	axonal regeneration	25549
@NP	mature neurons	25572
@NP	culture -LSB- 29,30 -RSB-	25590
@NP	culture	25590
@NP	29,30 -RSB-	25599
@NP	the heterogeneity in olfactory primary cultures	25616
@NP	the heterogeneity	25616
@NP	olfactory primary cultures	25637
@NP	the effectiveness of transplants	25688
@NP	the effectiveness	25688
@NP	transplants	25709
@NP	terms of promoting CNS repair -LSB- 5,20 -RSB-	25724
@NP	terms	25724
@NP	CNS repair -LSB- 5,20 -RSB-	25743
@NP	CNS repair	25743
@NP	5,20 -RSB-	25755
@NP	the homogeneity of pure OEG populations	25762
@NP	the homogeneity	25762
@NP	pure OEG populations	25781
@NP	their characterization	25819
@NP	the apparently different morphological types in primary cultures	25853
@NP	the apparently different morphological types	25853
@NP	primary cultures	25901
@NP	different states	25937
@NP	the same cell	25965
@NP	the microenvironment in culture -LSB- 6,32,34 -RSB-	25992
@NP	the microenvironment	25992
@NP	culture -LSB- 6,32,34 -RSB-	26016
@NP	culture	26016
@NP	6,32,34 -RSB-	26025
@NP	the present study	26038
@NP	TEG3 cells	26056
@NP	a fibroblast / astrocyte or Schwann-like appearance	26075
@NP	a fibroblast	26075
@NP	astrocyte or Schwann-like appearance	26089
@NP	astrocyte	26089
@NP	Schwann-like appearance	26102
@NP	the culture medium used	26139
@NP	the culture	26139
@NP	the different phenotypes in the primary OEG cultures	26170
@NP	the different phenotypes	26170
@NP	the primary OEG cultures	26198
@NP	different states of the same cells	26234
@NP	different states	26234
@NP	the same cells	26254
@NP	different stages in the same lineage -LSB- 27,33,34 -RSB-	26272
@NP	different stages	26272
@NP	the same lineage -LSB- 27,33,34 -RSB-	26292
@NP	the same lineage	26292
@NP	27,33,34 -RSB-	26310
@NP	TEG3	26321
@NP	one	26329
@NP	20 clonal OEG lines	26336
@NP	we	26361
@NP	the nuclear TSV40 in culture -LSB- 29,30 -RSB-	26420
@NP	the nuclear TSV40	26420
@NP	culture -LSB- 29,30 -RSB-	26441
@NP	culture	26441
@NP	29,30 -RSB-	26450
@NP	this study	26471
@NP	T-SV40 expression	26483
@NP	4 weeks	26529
@NP	transplant of TEG3 cells	26543
@NP	transplant	26543
@NP	TEG3 cells	26557
@NP	the injured spinal cord	26573
@NP	the TEG3 cells	26609
@NP	BrdU	26629
@NP	we	26634
@NP	this	26652
@NP	cell loss	26672
@NP	the silencing of the oncogene in vivo	26697
@NP	the silencing	26697
@NP	the oncogene in vivo	26714
@NP	the oncogene	26714
@NP	vivo	26730
@NP	another OEG-derived line	26774
@NP	the injured spinal cord -LSB- 26,37 -RSB-	26817
@NP	the injured spinal cord	26817
@NP	26,37 -RSB-	26842
@NP	other cellular systems -LSB- 38 -RSB-	26864
@NP	other cellular systems	26864
@NP	38 -RSB-	26888
@NP	It	26893
@NP	our TEG lines	26918
@NP	T-SV40	26933
@NP	the control of a cellular promoter -LRB- EF1a -RRB-	26949
@NP	the control	26949
@NP	a cellular promoter -LRB- EF1a -RRB-	26964
@NP	a cellular promoter	26964
@NP	EF1a	26985
@NP	a viral promoter -LSB- 26,37,38 -RSB-	27004
@NP	a viral promoter	27004
@NP	26,37,38 -RSB-	27022
@NP	a general transgene shutoff mechanism in vivo	27044
@NP	a general transgene shutoff mechanism	27044
@NP	vivo	27085
@NP	BrdU incorporation	27091
@NP	cell viability	27127
@NP	TEG3 cells	27187
@NP	as much as 10 weeks	27204
@NP	transplantation	27230
@NP	other studies of transplantation into the injured spinal cord	27250
@NP	other studies	27250
@NP	transplantation into the injured spinal cord	27267
@NP	transplantation	27267
@NP	the injured spinal cord	27288
@NP	it	27312
@NP	GFP-expressing OEGs	27343
@NP	transgenic mice for up to 28 days	27376
@NP	transgenic mice	27376
@NP	up to 28 days	27396
@NP	not 60 days	27415
@NP	39 -RSB-	27448
@NP	lentiviral OEG transduction	27461
@NP	persistent GFP expression for at least 4 months	27501
@NP	persistent GFP expression	27501
@NP	at least 4 months	27531
@NP	OEG implantation -LSB- 40 -RSB-	27555
@NP	OEG implantation	27555
@NP	40 -RSB-	27573
@NP	These data	27578
@NP	the persistence of transgene expression in vivo of genetically modified cells	27603
@NP	the persistence	27603
@NP	transgene expression in vivo of genetically modified cells	27622
@NP	transgene expression	27622
@NP	vivo	27646
@NP	genetically modified cells	27654
@NP	the original gene transfer method used -LSB- 39 -- 41 -RSB-	27695
@NP	the original gene transfer method	27695
@NP	39	27735
@NP	41 -RSB-	27738
@NP	TEG3 cells that integrated into the spinal cord	27743
@NP	TEG3 cells	27743
@NP	the spinal cord	27775
@NP	both the morphological and the intermediate features	27800
@NP	the morphological	27805
@NP	the intermediate features	27827
@NP	culture	27865
@NP	We	27874
@NP	TEG3 cells	27888
@NP	reactive astrocytes	27914
@NP	part	27948
@NP	their capacity to promote repair -LSB- 42 -RSB-	27972
@NP	repair -LSB- 42 -RSB-	27998
@NP	repair	27998
@NP	42 -RSB-	28006
@NP	We	28011
@NP	extensive migration of TEG3	28030
@NP	extensive migration	28030
@NP	TEG3	28053
@NP	the lesion site	28065
@NP	TEG3	28082
@NP	tumors	28104
@NP	we	28115
@NP	mitotic figures	28134
@NP	the down regulation of T-SV40 expression after transplantation	28172
@NP	the down regulation	28172
@NP	T-SV40 expression after transplantation	28195
@NP	T-SV40 expression	28195
@NP	transplantation	28219
@NP	this inhibition of proliferation in vivo	28257
@NP	this inhibition	28257
@NP	proliferation in vivo	28276
@NP	proliferation	28276
@NP	vivo	28293
@NP	other cells -LSB- 38 -RSB-	28316
@NP	other cells	28316
@NP	38 -RSB-	28329
@NP	integration of T-SV40 into the genome	28348
@NP	integration	28348
@NP	T-SV40 into the genome	28363
@NP	T-SV40	28363
@NP	the genome	28375
@NP	TEG3	28387
@NP	primary OEG in vivo	28410
@NP	primary OEG	28410
@NP	vivo	28425
@NP	other cells -LSB- 38 -RSB-	28457
@NP	other cells	28457
@NP	38 -RSB-	28470
@NP	Our data	28475
@NP	TEG3 cells	28494
@NP	axonal repair	28513
@NP	the spinal cord	28530
@NP	recovery of sensory and motor function	28558
@NP	recovery	28558
@NP	sensory and motor function	28570
@NP	sensory	28570
@NP	motor function	28582
@NP	the motor CST	28601
@NP	we	28615
@NP	axons that go through and beyond the lesion site in TEG3 - transplanted animals	28627
@NP	axons	28627
@NP	the lesion site	28660
@NP	TEG3	28679
@NP	transplanted animals	28685
@NP	there	28720
@NP	regrowth of sensory projections	28730
@NP	regrowth	28730
@NP	sensory projections	28742
@NP	the lesion site	28767
@NP	both tracts	28787
@NP	axons	28800
@NP	the transplanted cells	28835
@NP	some zones of TEG3 cells	28868
@NP	some zones	28868
@NP	TEG3 cells	28882
@NP	free of axons , and conversely axons	28909
@NP	axons	28917
@NP	the lesion site	28953
@NP	regions free of TEG3	28982
@NP	regions	28982
@NP	TEG3	28998
@NP	TEG3-mediated effects	29010
@NP	their direct contact	29058
@NP	the axons	29084
@NP	it	29103
@NP	they	29119
@NP	a bridging/supporting substrate	29131
@NP	the inhibitory influences of the glial scar	29177
@NP	the inhibitory influences	29177
@NP	the glial scar	29206
@NP	agreement with the anatomical findings	29225
@NP	agreement	29225
@NP	the anatomical findings	29240
@NP	functional recovery	29265
@NP	the animals transplanted with TEG3	29301
@NP	the animals	29301
@NP	TEG3	29331
@NP	These improvements	29337
@NP	the tape removal test	29373
@NP	the beam walking test	29415
@NP	TEG3-transplanted animals	29438
@NP	this task	29476
@NP	the first week after transplantation	29501
@NP	the first week	29501
@NP	transplantation	29522
@NP	later stages , until they almost reached	29545
@NP	later stages	29545
@NP	they	29565
@NP	the levels of control uninjured animals	29585
@NP	the levels	29585
@NP	control uninjured animals	29599
@NP	it	29632
@NP	TEG3 cells	29648
@NP	the initial devastating effects of the injury	29672
@NP	the initial devastating effects	29672
@NP	the injury	29707
@NP	functional recovery	29736
@NP	Different factors	29757
@NP	the two effects : functional and morphological preservation of the spinal cord	29794
@NP	the two effects	29794
@NP	functional and morphological preservation of the spinal cord	29811
@NP	functional and morphological preservation	29811
@NP	the spinal cord	29856
@NP	injury and sparing of axonal fibers	29878
@NP	injury and sparing	29878
@NP	axonal fibers	29900
@NP	modifications	29921
@NP	the glial scar	29938
@NP	TEG3	29956
@NP	axonal regrowth -LSB- 24,25,43 -- 47 -RSB-	29972
@NP	axonal regrowth -LSB- 24,25,43	29972
@NP	axonal regrowth	29972
@NP	24,25,43	29989
@NP	47 -RSB-	29998
@NP	TEG3-transplanted animals with motor improvement	30006
@NP	TEG3-transplanted animals	30006
@NP	motor improvement	30037
@NP	we	30056
@NP	the CST tract and a significant number of fibers exiting the lesion territory	30084
@NP	the CST tract	30084
@NP	a significant number of fibers exiting the lesion territory	30102
@NP	a significant number	30102
@NP	fibers exiting the lesion territory	30126
@NP	fibers	30126
@NP	the lesion territory	30141
@NP	it	30167
@NP	this	30189
@NP	the normal circuitry along the whole spinal cord	30229
@NP	the normal circuitry	30229
@NP	the whole spinal cord	30256
@NP	Regeneration of the corticospinal tract promoted by OEG	30279
@NP	Regeneration	30279
@NP	the corticospinal tract promoted by OEG	30295
@NP	the corticospinal tract	30295
@NP	OEG	30331
@NP	the 3 months	30377
@NP	the study -LRB- 5 and N10 mm at 1 and 3 months , respectively -RRB-	30393
@NP	the study	30393
@NP	5 and N10 mm at 1 and 3 months , respectively	30404
@NP	5 and N10 mm	30404
@NP	1 and 3 months , respectively	30420
@NP	1 and 3 months	30420
@NP	17 -RSB-	30451
@NP	most of the studies published to date	30464
@NP	most	30464
@NP	the studies published to date	30472
@NP	the studies	30472
@NP	date	30497
@NP	growth of regenerating axons through the lesion site	30520
@NP	growth	30520
@NP	axons	30543
@NP	the lesion site	30557
@NP	axonal regrowth over long distances	30627
@NP	axonal regrowth	30627
@NP	long distances	30648
@NP	reconnection with original targets	30667
@NP	reconnection	30667
@NP	original targets	30685
@NP	examples -LSB- 16 -- 18,35,41,47 -RSB-	30710
@NP	examples	30710
@NP	16 -- 18,35,41,47	30720
@NP	Plasticity	30738
@NP	a large role	30758
@NP	the functional recuperation of the injured adult spinal cord	30774
@NP	the functional recuperation	30774
@NP	the injured adult spinal cord	30805
@NP	dorsal hemisection of the spinal cord	30842
@NP	dorsal hemisection	30842
@NP	the spinal cord	30864
@NP	reactive sprouting	30881
@NP	the establishment	30904
@NP	new intraspinal circuits through contacts with long propriospinal interneurons	30925
@NP	new intraspinal circuits	30925
@NP	contacts with long propriospinal interneurons	30958
@NP	contacts	30958
@NP	long propriospinal interneurons	30972
@NP	cortical input	31038
@NP	original spinal targets	31056
@NP	spontaneous functional recovery in adult rats -LSB- 48 -RSB-	31094
@NP	spontaneous functional recovery	31094
@NP	adult rats -LSB- 48 -RSB-	31129
@NP	adult rats	31129
@NP	48 -RSB-	31141
@NP	the role	31152
@NP	TEG3	31164
@NP	CST	31182
@NP	long-distance local circuits in the cervical spinal cord	31219
@NP	long-distance local circuits	31219
@NP	the cervical spinal cord	31251
@NP	the recovery of motor functions in the TEG3-transplanted animals	31300
@NP	the recovery	31300
@NP	motor functions in the TEG3-transplanted animals	31316
@NP	motor functions	31316
@NP	the TEG3-transplanted animals	31335
@NP	We	31366
@NP	the contribution	31384
@NP	ventral or dorsolateral/lateral CST	31417
@NP	b5 and b2 % of the CST tract , respectively	31454
@NP	b5 and b2 % of the CST tract	31454
@NP	b5	31454
@NP	b2 % of the CST tract	31461
@NP	b2 %	31461
@NP	the CST tract	31468
@NP	rubrospinal projections	31507
@NP	Nontumorigenic human OEG clonal lines that maintain neuroregenerative properties	31532
@NP	Nontumorigenic human OEG clonal lines	31532
@NP	neuroregenerative properties	31584
@NP	numerous practical advantages	31624
@NP	primary OEG clinical purposes -LSB- 6,49,50 -RSB-	31659
@NP	primary OEG clinical purposes	31659
@NP	6,49,50 -RSB-	31690
@NP	research with OEG clonal lines	31707
@NP	research	31707
@NP	OEG clonal lines	31721
@NP	an important role to play in the development of therapies to repair CNS lesions	31742
@NP	the development of therapies	31771
@NP	the development	31771
@NP	therapies	31790
@NP	CNS lesions	31810
@NP	MATERIALS AND METHODS	31824
@NP	TEG3 Culture	31846
@NP	We	31859
@NP	the isolation	31888
@NP	the immortalized clonal cell line TEG3	31905
@NP	a SV40 large T antigen	31954
@NP	OEG primary cultures prepared from adult rat	32000
@NP	OEG primary cultures	32000
@NP	adult rat	32035
@NP	olfactory bulbs	32045
@NP	29,30 -RSB-	32062
@NP	TEG3 cells	32070
@NP	M10 -LRB- DMEM supplemented with 10 % FCS -RRB-	32100
@NP	M10	32100
@NP	DMEM supplemented with 10 % FCS	32105
@NP	DMEM	32105
@NP	10 % FCS	32128
@NP	ME10	32138
@NP	DMEM	32144
@NP	F12 supplemented with 10 % FCS , 20 µg/ml pituitary extract , and 2 µM forskolin	32149
@NP	F12	32149
@NP	10 % FCS , 20 µg/ml pituitary extract , and 2 µM forskolin	32171
@NP	10 % FCS	32171
@NP	20 µg/ml pituitary extract	32180
@NP	20 µg/ml	32180
@NP	2 µM forskolin	32212
@NP	ME3 -LRB- DMEM + 3 % FCS , 20 µg/ml pituitary extract , and 1 µM forskolin -RRB-	32232
@NP	ME3	32232
@NP	DMEM + 3 % FCS	32237
@NP	DMEM	32237
@NP	3 % FCS	32244
@NP	20 µg/ml pituitary extract , and 1 µM forskolin	32252
@NP	20 µg/ml	32252
@NP	pituitary extract	32261
@NP	1 µM forskolin	32284
@NP	Spinal Cord Injury and TEG3 Transplantation All animal experimentation	32301
@NP	Spinal Cord Injury	32301
@NP	TEG3 Transplantation All animal experimentation	32324
@NP	TEG3 Transplantation	32324
@NP	All animal experimentation	32345
@NP	animal facilities	32391
@NP	Institutional Registration No. 28079-19A , Spanish Ministry of Agriculture	32410
@NP	Institutional Registration	32410
@NP	No. 28079-19A , Spanish Ministry of Agriculture	32437
@NP	No. 28079-19A	32437
@NP	Spanish Ministry of Agriculture	32452
@NP	Spanish Ministry	32452
@NP	Agriculture	32472
@NP	the Spanish Royal Decree 223/1988	32500
@NP	the European Council Directive 86/609/EEC -LRB- 1986 -RRB-	32549
@NP	the European Council Directive 86/609/EEC	32549
@NP	1986	32592
@NP	national and institutional bioethics	32615
@NP	committees	32652
@NP	The capacity of TEG3 to promote neuronal repair	32664
@NP	The capacity	32664
@NP	TEG3 to promote neuronal repair	32680
@NP	neuronal repair	32696
@NP	three independent experiments with a combined total of 44 adult male Wistar rats	32728
@NP	three independent experiments	32728
@NP	a combined total of 44 adult male Wistar rats	32763
@NP	a combined total	32763
@NP	44 adult male Wistar rats	32783
@NP	6	32810
@NP	control unoperated animals	32817
@NP	6	32845
@NP	sham operations	32857
@NP	anesthesia	32879
@NP	32	32895
@NP	anesthesia	32921
@NP	a bilateral lesion in the dorsal columns	32943
@NP	a bilateral lesion	32943
@NP	the dorsal columns	32965
@NP	spinal level C3 using watchmaker 's forceps -LSB- 35 -RSB-	32987
@NP	spinal level C3	32987
@NP	watchmaker 's forceps -LSB- 35 -RSB-	33009
@NP	watchmaker 's forceps	33009
@NP	watchmaker 's	33009
@NP	35 -RSB-	33031
@NP	the 32 lesioned rats	33039
@NP	20	33061
@NP	the TEG3 clonal line	33087
@NP	a further group of 12 animals	33112
@NP	a further group	33112
@NP	12 animals	33131
@NP	the cell suspension vehicle only -LRB- DMEM -RRB-	33151
@NP	the cell suspension vehicle only	33151
@NP	DMEM	33185
@NP	TEG3 cells	33206
@NP	a total of 3 x 10 ^ 5 cells -LRB- 1 x 10 ^ 5 cells/µl -RRB-	33218
@NP	a total	33218
@NP	3 x 10 ^ 5 cells -LRB- 1 x 10 ^ 5 cells/µl -RRB-	33229
@NP	3 x 10 ^ 5 cells	33229
@NP	3 x	33229
@NP	10 ^ 5 cells	33233
@NP	1 x 10 ^ 5 cells/µl	33245
@NP	1	33245
@NP	10 ^ 5 cells/µl	33249
@NP	a Hamilton syringe	33283
@NP	a glass micropipette	33313
@NP	the dorsal half of the spinal cord -LRB- depth 2 mm -RRB-	33340
@NP	the dorsal half	33340
@NP	the spinal cord -LRB- depth 2 mm -RRB-	33359
@NP	the spinal cord	33359
@NP	depth 2 mm	33376
@NP	depth	33376
@NP	2 mm	33382
@NP	three rostrocaudal levels	33391
@NP	the lesion site and 1 mm caudal	33421
@NP	the lesion site	33421
@NP	1 mm caudal	33441
@NP	rostral	33460
@NP	the lesion -LRB- 1 µl/min/site ; a total of 3 Al -RRB-	33471
@NP	the lesion	33471
@NP	1 µl/min/site ; a total of 3 Al	33483
@NP	1 µl/min/site	33483
@NP	a total of 3 Al	33498
@NP	a total of 3	33498
@NP	Al	33511
@NP	one set	33530
@NP	animals	33541
@NP	n	33550
@NP	26	33554
@NP	6 sham-operated rats , 6 mock-transplanted with DMEM	33558
@NP	6 sham-operated rats	33558
@NP	DMEM	33605
@NP	14 transplanted with TEG3 cells	33615
@NP	14 transplanted	33615
@NP	TEG3 cells	33636
@NP	tissues	33667
@NP	transcardial perfusion	33689
@NP	1 -LRB- n = 6 -RRB-	33715
@NP	1	33715
@NP	n	33718
@NP	6	33722
@NP	2 -LRB- n = 4 -RRB-	33726
@NP	2	33726
@NP	n	33729
@NP	4	33733
@NP	4 -LRB- n = 10 -RRB-	33737
@NP	4	33737
@NP	n	33740
@NP	10	33744
@NP	8 weeks -LRB- n = 6 -RRB-	33753
@NP	n	33762
@NP	6	33766
@NP	These animals	33770
@NP	detailed anatomical analysis	33797
@NP	the ascending sensory projections and descending CST	33829
@NP	the	33829
@NP	sensory projections	33843
@NP	CST	33878
@NP	analysis	33898
@NP	the in vivo properties of TEG3	33910
@NP	properties of TEG3	33922
@NP	properties	33922
@NP	TEG3	33936
@NP	survival , migration ability , and tumor formation	33942
@NP	survival	33942
@NP	migration ability	33952
@NP	tumor formation	33975
@NP	remaining animals	33996
@NP	n	34015
@NP	18	34019
@NP	6 control unoperated animals , 6 mock-transplanted with DMEM	34023
@NP	6 control unoperated animals	34023
@NP	DMEM	34078
@NP	6 transplanted with TEG3 cells	34088
@NP	6 transplanted	34088
@NP	TEG3 cells	34108
@NP	motor and sensory tasks	34140
@NP	spinal cord injury	34171
@NP	Behavioral Assessment	34207
@NP	They	34237
@NP	behavioral tests	34259
@NP	8 weeks	34276
@NP	injury	34290
@NP	their tissue	34345
@NP	transcardial perfusion	34371
@NP	10 weeks	34394
@NP	injury	34409
@NP	The spinal cords	34417
@NP	these animals	34456
@NP	the brain stem	34474
@NP	two cervical segments	34490
@NP	rostral	34513
@NP	lesion site and caudal to lesion site , comprising C1 -- C7 , approximately	34524
@NP	lesion site and caudal	34524
@NP	lesion site	34550
@NP	C1 -- C7 , approximately	34574
@NP	C1	34574
@NP	C7 , approximately	34578
@NP	C7	34578
@NP	one lumbar segment	34602
@NP	each animal	34641
@NP	Tissue	34654
@NP	Tissue Tek -LRB- Sakura -RRB- and quick frozen -LRB- with liquid nitrogen -RRB-	34677
@NP	Tissue Tek	34677
@NP	Sakura	34689
@NP	quick frozen	34701
@NP	liquid nitrogen	34720
@NP	Serial cryostat sagittal sections -LRB- 20 µm -RRB-	34738
@NP	Serial cryostat sagittal sections	34738
@NP	20 µm	34773
@NP	these animals	34798
@NP	the anatomical analysis of ascending and descending tracts of the dorsal columns	34812
@NP	the anatomical analysis	34812
@NP	tracts of the dorsal columns	34864
@NP	tracts	34864
@NP	the dorsal columns	34874
@NP	the functional recovery in sensory and motor performance	34913
@NP	the functional recovery	34913
@NP	sensory and motor performance	34940
@NP	sensory	34940
@NP	motor performance	34952
@NP	fibers	34979
@NP	sagittal spinal cord sections	35005
@NP	ExtrAvidin	35040
@NP	fluorescein isothiocyanate -LRB- FITC ; Sigma ; 1:500 -RRB-	35065
@NP	fluorescein isothiocyanate	35065
@NP	FITC	35093
@NP	Sigma ; 1:500	35099
@NP	Sigma	35099
@NP	1:500	35106
@NP	Immunofluorescence .	35133
@NP	Staining of serial sagittal spinal cord sections -LRB- 20 µm -RRB-	35153
@NP	Staining	35153
@NP	serial sagittal spinal cord sections -LRB- 20 µm -RRB-	35165
@NP	serial sagittal spinal cord sections	35165
@NP	20 µm	35203
@NP	mouse monoclonal antibodies	35229
@NP	T-SV40	35265
@NP	PharMingen International ; diluted 1:250 -RRB-	35273
@NP	PharMingen International	35273
@NP	diluted 1:250	35299
@NP	diluted	35299
@NP	1:250	35307
@NP	BrdU	35315
@NP	Sigma ; diluted 1:100 -RRB- , and GFAP -LRB- Boehringer Mannheim ; diluted 1:500	35321
@NP	Sigma ; diluted 1:100 -RRB-	35321
@NP	Sigma	35321
@NP	diluted 1:100	35328
@NP	diluted	35328
@NP	1:100	35336
@NP	GFAP -LRB- Boehringer Mannheim ; diluted 1:500	35348
@NP	GFAP -LRB- Boehringer Mannheim ;	35348
@NP	GFAP	35348
@NP	Boehringer Mannheim	35354
@NP	Boehringer	35354
@NP	Mannheim	35365
@NP	1:500	35383
@NP	with rabbit polyclonal antisera against GFAP -LRB- Promega ; diluted 1:1000	35394
@NP	with rabbit polyclonal antisera against GFAP -LRB- Promega ;	35394
@NP	rabbit polyclonal antisera	35399
@NP	GFAP -LRB- Promega ;	35434
@NP	GFAP	35434
@NP	Promega	35440
@NP	1:1000	35457
@NP	PGDH -LRB- a generous gift from Dr.	35466
@NP	PGDH	35466
@NP	a generous gift from Dr.	35472
@NP	a generous gift	35472
@NP	Dr.	35493
@NP	Watanabe , diluted 1:250 -RRB-	35497
@NP	Watanabe	35497
@NP	diluted 1:250	35507
@NP	diluted	35507
@NP	1:250	35515
@NP	PKC-g -LRB- Santa Cruz ; diluted 1:1000 -RRB-	35523
@NP	PKC-g	35523
@NP	Santa Cruz ; diluted 1:1000	35530
@NP	Santa Cruz	35530
@NP	diluted 1:1000	35542
@NP	diluted	35542
@NP	1:1000	35550
@NP	a goat polyclonal antiserum	35563
@NP	CTB -LRB- List Biological Laboratories , Inc. ; 1:2000 -RRB-	35599
@NP	CTB	35599
@NP	List	35604
@NP	Biological Laboratories , Inc. ; 1:2000	35609
@NP	Biological Laboratories	35609
@NP	Inc.	35634
@NP	1:2000	35640
@NP	The primary antibodies	35649
@NP	immunofluorescence	35691
@NP	the preparations	35717
@NP	they	35747
@NP	the appropriate secondary antibodies conjugated to FITC	35772
@NP	the appropriate secondary antibodies	35772
@NP	FITC	35823
@NP	tetramethylrhodamine isothiocyanate -LRB- Jackson Laboratories -RRB-	35829
@NP	tetramethylrhodamine isothiocyanate	35829
@NP	Jackson Laboratories	35866
@NP	488	35889
@NP	Alexa -LRB- Molecular Probes -RRB-	35897
@NP	Alexa	35897
@NP	Molecular Probes	35904
@NP	the preparations	35932
@NP	Fluoromount -LRB- Southern Biotechnologies -RRB-	35978
@NP	Fluoromount	35978
@NP	Southern Biotechnologies	35991
@NP	BDA-labeled fibers	36018
@NP	sagittal spinal cord sections with ExtrAvidin	36056
@NP	sagittal spinal cord sections	36056
@NP	ExtrAvidin	36091
@NP	FITC -LRB- Sigma ; 1:500 -RRB- after the signal	36102
@NP	FITC -LRB- Sigma ; 1:500 -RRB-	36102
@NP	FITC	36102
@NP	Sigma ; 1:500	36108
@NP	Sigma	36108
@NP	1:500	36115
@NP	the signal	36128
@NP	the ABC Kit	36158
@NP	Vector Laboratories	36171
@NP	Burlingame	36192
@NP	CA , USA	36204
@NP	biotinyl tyramide	36217
@NP	NEN Life Science Products	36236
@NP	Histological Quantification	36264
@NP	Statistical Analysis BrdU-labeled cells in the spinal cord	36296
@NP	Statistical Analysis BrdU-labeled cells	36296
@NP	the spinal cord	36339
@NP	the injury site at different times	36374
@NP	the injury site	36374
@NP	different times	36393
@NP	injection -LRB- 2 , 4 , 10 weeks -RRB-	36415
@NP	injection	36415
@NP	2	36426
@NP	4	36429
@NP	10 weeks	36432
@NP	The results	36443
@NP	the means	36468
@NP	SEM	36480
@NP	n	36485
@NP	3 or 4 animals	36489
@NP	at least three sections/animal	36505
@NP	the second series of slides from the cervical spinal cord	36539
@NP	the second series	36539
@NP	slides from the cervical spinal cord	36560
@NP	slides	36560
@NP	the cervical spinal cord	36572
@NP	the same level in all the animals	36601
@NP	the same level	36601
@NP	all the animals	36619
@NP	the center of the lesion	36653
@NP	the center	36653
@NP	the lesion	36667
@NP	each sacrifice time point	36683
@NP	The number of BDA-labeled axons	36710
@NP	The number	36710
@NP	BDA-labeled axons	36724
@NP	an independent observer	36760
@NP	different distances , rostral to , within	36787
@NP	different distances	36787
@NP	rostral to	36808
@NP	rostral	36808
@NP	caudal to the lesion site in TEG3 - and mock-transplanted animals	36832
@NP	caudal	36832
@NP	the lesion site in TEG3 - and mock-transplanted animals	36842
@NP	the lesion site	36842
@NP	TEG3 - and mock-transplanted animals	36861
@NP	means	36898
@NP	SEM	36906
@NP	n = 3 each group	36911
@NP	n	36911
@NP	= 3 each group	36913
@NP	3	36915
@NP	at least three sections/animal	36929
@NP	the second series of slides from the cervical spinal cord	36963
@NP	the second series	36963
@NP	slides from the cervical spinal cord	36984
@NP	slides	36984
@NP	the cervical spinal cord	36996
@NP	the same level in all the animals	37025
@NP	the same level	37025
@NP	all the animals	37043
@NP	the center of the lesion	37077
@NP	the center	37077
@NP	the lesion	37091
@NP	The results	37104
@NP	the distance	37140
@NP	lesion	37158
@NP	units	37166
@NP	distance	37175
@NP	each unit	37185
@NP	500 µm , the point 0	37206
@NP	500 µm	37206
@NP	the point 0	37214
@NP	the point	37214
@NP	0	37224
@NP	the center of the lesion site	37232
@NP	the center	37232
@NP	the lesion site	37246
@NP	the negative and positive numbers on the abscissa	37263
@NP	the negative and positive numbers	37263
@NP	the abscissa	37300
@NP	the areas rostral and caudal	37327
@NP	the lesion site	37359
@NP	Statistical analysis	37391
@NP	ANOVA	37432
@NP	a factor	37444
@NP	Tukey and Bonferroni	37482
@NP	hoc	37508
@NP	tests	37512
@NP	comparison	37537
@NP	individual means	37551
@NP	Tukey results	37574
@NP	they	37601
@NP	Bonferroni results	37620
@NP	Behavioral Assessment	37641
@NP	We	37663
@NP	a group	37675
@NP	18 animals	37686
@NP	two behavioral tests of motor and sensory function	37703
@NP	two behavioral tests	37703
@NP	motor and sensory function	37727
@NP	adhesive tape removal and beam walking	37755
@NP	35 -RSB- and references	37796
@NP	Three groups of rats	37825
@NP	Three groups	37825
@NP	rats	37841
@NP	tasks	37870
@NP	a daily basis	37879
@NP	1 week	37893
@NP	the injury/transplant	37907
@NP	2 days	37934
@NP	surgery	37948
@NP	the baseline	37956
@NP	one group	37999
@NP	an unlesioned control group -LRB- n = 6 -RRB-	38021
@NP	an unlesioned control group	38021
@NP	n	38050
@NP	6	38054
@NP	the second group	38067
@NP	the lesion of the spinal cord	38084
@NP	the lesion	38084
@NP	the spinal cord	38098
@NP	transplantation of TEG3 -LRB- n = 6 -RRB-	38142
@NP	transplantation	38142
@NP	TEG3 -LRB- n = 6 -RRB-	38161
@NP	TEG3	38161
@NP	n	38167
@NP	6	38171
@NP	A third group	38175
@NP	the dorsal column lesion of the spinal cord and a mock transplant	38198
@NP	the dorsal column lesion	38198
@NP	the spinal cord and a mock transplant	38226
@NP	the spinal cord	38226
@NP	a mock transplant	38246
@NP	vehicle only -LRB- DMEM , n = 6 -RRB-	38269
@NP	vehicle only	38269
@NP	DMEM , n = 6	38283
@NP	DMEM	38283
@NP	n = 6	38289
@NP	n	38289
@NP	6	38293
@NP	One week	38297
@NP	surgery	38312
@NP	a week	38329
@NP	the 8th week	38342
@NP	the animals	38379
@NP	the two tests	38419
@NP	I	38435
@NP	The tape removal test , producing separate scores for sensory and motor behavior	38438
@NP	The tape removal test	38438
@NP	producing separate scores for sensory and motor behavior	38461
@NP	producing separate scores	38461
@NP	sensory and motor behavior	38491
@NP	sensory	38491
@NP	motor behavior	38503
@NP	-LSB- 35 -RSB-	38536
@NP	Adhesive tape -LRB- 0.9 x 2.5 cm -RRB-	38542
@NP	Adhesive tape	38542
@NP	0.9 x 2.5 cm	38557
@NP	0.9	38557
@NP	2.5 cm	38563
@NP	the left forepaw	38585
@NP	the time	38606
@NP	the presence of the tape -LRB- indicated by paw shake -RRB-	38630
@NP	the presence	38630
@NP	the tape -LRB- indicated by paw shake -RRB-	38646
@NP	the tape	38646
@NP	paw shake	38669
@NP	animals that sensed the tape	38700
@NP	animals	38700
@NP	the tape	38720
@NP	the removal time	38730
@NP	II	38765
@NP	The locomotor task	38769
@NP	beam walking	38789
@NP	sensorimotor integration	38814
@NP	-LSB- 35	38857
@NP	Rats	38863
@NP	a narrow metal beam -LRB- 3 x 90 cm -RRB-	38890
@NP	a narrow metal beam	38890
@NP	3 x 90 cm	38911
@NP	3 x	38911
@NP	90 cm	38915
@NP	they	38926
@NP	video	38948
@NP	beam walking testing -LRB- see supplementary data video for examples -RRB-	38958
@NP	beam walking testing	38958
@NP	supplementary data video	38984
@NP	examples	39013
@NP	The sum of both front and rear paw foot	39024
@NP	The sum	39024
@NP	both front and rear paw foot	39035
@NP	front	39040
@NP	rear paw foot	39050
@NP	the paw slipping off the beam	39098
@NP	the paw	39098
@NP	the beam	39119
@VP	Immortalized Olfactory Ensheathing Glia	25
@VP	Promotes Functional Recovery in the Injured Spinal Cord M.	65
@VP	Injured Spinal Cord M.	101
@VP	maintain the proregenerative properties of primary cultures	660
@VP	provide an unlimited source of OEG for both basic and applied studies	720
@VP	proved to be as good	852
@VP	to be as good	859
@VP	be as good	862
@VP	promoting neuritogenesis and axon regeneration in culture models	891
@VP	are cultured	1199
@VP	cultured	1203
@VP	survived for at least 10 weeks after grafting	1257
@VP	grafting	1294
@VP	adopting Schwann cell-like , astrocyte-like , or intermediate morphologies	1345
@VP	grow into the lesion site	1474
@VP	crushing of the spinal cord -- dorsal columns	1617
@VP	immortalized cell lines derived from a single cell	1813
@VP	derived from a single cell	1837
@VP	can maintain the regenerative properties of primary OEG	1864
@VP	maintain the regenerative properties of primary OEG	1868
@VP	regenerate poorly	2043
@VP	to study CNS regeneration	2157
@VP	study CNS regeneration	2160
@VP	approaches -LSB- 2 -- 9 -RSB-	2290
@VP	distinguishes the mammalian olfactory system	2495
@VP	reach their targets in the olfactory bulb -LSB- 10 -- 13 -RSB-	2739
@VP	growing into the adult mammalian CNS	2834
@VP	might facilitate axonal regeneration in the injured CNS -LSB- 14,15 -RSB-	2910
@VP	facilitate axonal regeneration in the injured CNS -LSB- 14,15 -RSB-	2916
@VP	has been confirmed in several studies -LSB- 16 -- 19 -RSB-	3051
@VP	been confirmed in several studies -LSB- 16 -- 19 -RSB-	3055
@VP	confirmed in several studies -LSB- 16 -- 19 -RSB-	3060
@VP	are responsible for their effects on regeneration	3148
@VP	remain to be elucidated -LSB- 2,5,6,20 -RSB-	3198
@VP	to be elucidated -LSB- 2,5,6,20 -RSB-	3205
@VP	be elucidated -LSB- 2,5,6,20 -RSB-	3208
@VP	elucidated -LSB- 2,5,6,20 -RSB-	3211
@VP	to study OEGs in culture	3246
@VP	study OEGs in culture	3249
@VP	facilitates the characterization of their regenerative activity	3271
@VP	see -LSB- 5 -RSB-	3612
@VP	is labor-intensive and tedious	3669
@VP	is subject to batch-to-batch variability	3704
@VP	are limited	3767
@VP	is important for transplants to promote CNS repair effectively -LSB- 5,20 -RSB-	3900
@VP	to promote CNS repair effectively -LSB- 5,20 -RSB-	3929
@VP	promote CNS repair effectively -LSB- 5,20 -RSB-	3932
@VP	can be more completely characterized	4043
@VP	be more completely characterized	4047
@VP	more completely characterized	4050
@VP	have been used successfully to purify and transplant OEG cells -LSB- 14,16	4116
@VP	been used successfully to purify and transplant OEG cells -LSB- 14,16	4121
@VP	used successfully to purify and transplant OEG cells -LSB- 14,16	4126
@VP	to purify and transplant OEG cells -LSB- 14,16	4144
@VP	purify and transplant OEG cells -LSB- 14,16	4147
@VP	mean that no two laboratories are studying fully comparable cells	4256
@VP	are studying fully comparable cells	4286
@VP	studying fully comparable cells	4290
@VP	retain the capacity to promote axonal regeneration of primary OEG cultures	4359
@VP	to promote axonal regeneration of primary OEG cultures	4379
@VP	promote axonal regeneration of primary OEG cultures	4382
@VP	providing an unlimited supply of homogeneous OEG cells -LSB- 6,26 -- 28 -RSB-	4451
@VP	promoting neuritogenesis and axonal regeneration in culture	4685
@VP	being TEG3 -LSB- 29,30 -RSB-	4770
@VP	survive in the injured spinal cord for at least 10 weeks after transplantation	5130
@VP	integrate into the sites of lesion	5229
@VP	adopt morphologies similar to those found in culture , without forming tumors	5268
@VP	found in culture , without forming tumors	5304
@VP	forming tumors	5330
@VP	permitting recovery of motor and sensory function	5471
@VP	immortalized OEG clonal line derived from a single cell	5533
@VP	derived from a single cell	5562
@VP	is capable of promoting recovery in the injured spinal cord	5589
@VP	promoting recovery in the injured spinal cord	5603
@VP	FIG. 1	5659
@VP	using the large T antigen of SV40 -LRB- T-SV40 -RRB-	5770
@VP	is shown	5922
@VP	shown	5925
@VP	see Materials and Methods	6001
@VP	were incubated with BrdU 18 -- 20 h prior to transplant	6381
@VP	incubated with BrdU 18 -- 20 h prior to transplant	6386
@VP	survived for 4 weeks after transplant	6632
@VP	sacrificed at 2	6991
@VP	are represented in the ordinate versus the time of sacrifice on the abscissa	7155
@VP	represented in the ordinate versus the time of sacrifice on the abscissa	7159
@VP	showing the fate of TEG3 cells after transplant into the lesioned spinal cord	7352
@VP	were labeled with BrdU prior to transplantation	7442
@VP	labeled with BrdU prior to transplantation	7447
@VP	transplanted with TEG3 -LRB- A -- C , E , and F -RRB-	7683
@VP	mocktransplanted with vehicle only	7725
@VP	intermingled with reactive astrocytes -LRB- red processes in B -RRB-	8267
@VP	appears yellow in -LRB- B -RRB-	8373
@VP	mediated by TEG3 in the spinal cord after dorsal column crush	8531
@VP	were labeled by injection of cholera toxin B-subunit -LRB- CTB -RRB-	8629
@VP	labeled by injection of cholera toxin B-subunit -LRB- CTB -RRB-	8634
@VP	-LRB- B , E , and G -RRB- Magnified	9079
@VP	dashed	9169
@VP	contained many TEG3 cells -LRB- C -RRB-	9354
@VP	can be observed in B -LRB- arrowheads -RRB-	9410
@VP	be observed in B -LRB- arrowheads -RRB-	9414
@VP	observed in B -LRB- arrowheads -RRB-	9417
@VP	were observed within the lesion area -LRB- asterisk in F -RRB-	9512
@VP	observed within the lesion area -LRB- asterisk in F -RRB-	9517
@VP	see dashed line in F	9616
@VP	dashed line in F	9620
@VP	turning 1808 to face away from the lesioned area -LRB- asterisks in G -RRB-	9668
@VP	to face away from the lesioned area -LRB- asterisks in G -RRB-	9681
@VP	face away from the lesioned area -LRB- asterisks in G -RRB-	9684
@VP	Confocal microscopy	9768
@VP	promoted by TEG3 in the spinal cord after dorsal column crush	9932
@VP	biotinylated dextran amine -LRB- BDA -RRB- into the motor cortex	10067
@VP	is shown	10187
@VP	shown	10190
@VP	sacrificed at 10 weeks after transplant	10285
@VP	show magnified views of BDA-traced fibers of the CST rostral to the lesion site	10333
@VP	magnified views of BDA-traced fibers of the CST rostral to the lesion site	10338
@VP	corresponds to a higher power view of BDA-traced fibers in the lesion site	10521
@VP	sprouting	10649
@VP	inset in B	10729
@VP	navigating between TEG3 cells	10741
@VP	stained red for BrdU in B and inset in B	10772
@VP	stained red for BrdU in B	10772
@VP	inset in B	10802
@VP	can be observed extending away from the lesion site	10888
@VP	be observed extending away from the lesion site	10892
@VP	observed extending away from the lesion site	10895
@VP	extending away from the lesion site	10904
@VP	approaching the lesion site -LRB- D , closer view of the left square in E -RRB-	11023
@VP	extend away from the lesion site	11162
@VP	± SEM , n = 3 each group	11324
@VP	is the center of the lesion site	11432
@VP	represent areas rostral and caudal to the lesion site , respectively	11496
@VP	< 0.01 -LRB- ANOVA and Tukey post hoc test -RRB-	11583
@VP	To assess total ablation of the CST caudal to the lesion site	11623
@VP	assess total ablation of the CST caudal to the lesion site	11626
@VP	operated animals -LRB- 10 weeks after lesion/transplant -RRB-	11810
@VP	-LRB- H -RRB- In all lesioned animals	11964
@VP	disappeared at the lumbar level -LRB- arrowhead -RRB-	12019
@VP	, inset in A , C , and D , 100 µm	12071
@VP	, inset in A , C ,	12071
@VP	inset in A , C ,	12073
@VP	inset in B	12106
@VP	induced by injecting TEG3 cells into the injured spinal cord	12194
@VP	injecting TEG3 cells into the injured spinal cord	12205
@VP	were tested and subsequently sacrificed at 10 weeks for histological analysis	12339
@VP	tested and subsequently sacrificed at 10 weeks for histological analysis	12344
@VP	tested	12344
@VP	subsequently sacrificed at 10 weeks for histological analysis	12355
@VP	-LRB- A and B -RRB- In the tape removal task	12418
@VP	transplanted with vehicle	12473
@VP	to remove the adhesive tape	12607
@VP	remove the adhesive tape	12610
@VP	transplanted with TEG3 cells	12735
@VP	made a moderate functional recovery but did not reach control latencies	12764
@VP	made a moderate functional recovery	12764
@VP	did not reach control latencies	12804
@VP	reach control latencies	12812
@VP	transplanted with vehicle	12878
@VP	made significantly more foot-slip errors than controls	12904
@VP	transplanted with TEG3 cells	12987
@VP	achieved a marked functional recovery in this task	13016
@VP	did not differ significantly from those of the control unoperated group	13092
@VP	differ significantly from those of the control unoperated group	13100
@VP	-LSB- 29,30 -RSB-	13532
@VP	were originally maintained in simple medium -LRB- M10 -RRB-	13553
@VP	maintained in simple medium -LRB- M10 -RRB-	13569
@VP	see Materials and Methods	13675
@VP	adopted a bipolar morphology -LRB- Figs. 1A and B , and data not shown	13838
@VP	not shown	13893
@VP	altering the medium	13968
@VP	can exhibit different morphological features depending on their microenvironment	14021
@VP	exhibit different morphological features depending on their microenvironment	14025
@VP	evaluate the capacity of TEG3 cells to promote repair in the injured CNS in vivo	14381
@VP	to promote repair in the injured CNS in vivo	14417
@VP	promote repair in the injured CNS in vivo	14420
@VP	producing the lesion	14607
@VP	injected TEG3 cells into the animals	14632
@VP	injecting control animals with the vehicle	14676
@VP	tested sham-operated and unoperated control animals in parallel	14734
@VP	detected in vivo by immunostaining for SV40 large T antigen -LRB- T-SV40 -RRB-	14823
@VP	-RRB-	15096
@VP	expressing T-SV40	15119
@VP	had decreased 2 weeks after injury -LRB- Supplementary Figs	15137
@VP	decreased 2 weeks after injury -LRB- Supplementary Figs	15141
@VP	expressing the T-SV40	15236
@VP	could be seen in vivo -LRB- Fig. 2C -RRB-	15258
@VP	be seen in vivo -LRB- Fig. 2C -RRB-	15264
@VP	seen in vivo -LRB- Fig. 2C -RRB-	15267
@VP	was due to silencing of the gene rather than the loss of TEG3 cells	15333
@VP	found that the viability of the TEG3 cells was higher than 90 %	15501
@VP	was higher than 90 %	15544
@VP	could be readily detected by anti- BrdU immunostaining -LRB- Supplementary Fig	15623
@VP	be readily detected by anti- BrdU immunostaining -LRB- Supplementary Fig	15629
@VP	readily detected by anti- BrdU immunostaining -LRB- Supplementary Fig	15632
@VP	was not detected at these time points	15766
@VP	detected at these time points	15774
@VP	-LRB- compare Supplementary Figs	15804
@VP	compare Supplementary Figs	15805
@VP	saw 685 ± 65 nuclei/field -LRB- x250 ; n = 4 -RRB-	16160
@VP	remained in the center of the damaged area after 4 and 10 weeks	16630
@VP	remained around the area of the lesion	16723
@VP	were dispersed along the dorsoventral axis in some animals	16762
@VP	dispersed along the dorsoventral axis in some animals	16767
@VP	see Fig. 1	17098
@VP	integrated in the spinal cord territory	17126
@VP	to intermingle with reactive astrocytes in the lesion area -LRB- Fig. 3B -RRB-	17309
@VP	intermingle with reactive astrocytes in the lesion area -LRB- Fig. 3B -RRB-	17312
@VP	had used the oncogene T-SV40 to immortalize the OEG cells	17388
@VP	used the oncogene T-SV40 to immortalize the OEG cells	17392
@VP	to immortalize the OEG cells	17417
@VP	immortalize the OEG cells	17420
@VP	was also important to analyze their tumorigenic potential in vivo	17450
@VP	to analyze their tumorigenic potential in vivo	17469
@VP	analyze their tumorigenic potential in vivo	17472
@VP	examined	17564
@VP	grafted with TEG3 cells	17630
@VP	see Figs. 2 and 3	17655
@VP	Injured Spinal Cord Anatomical analysis of TEG3-induced axonal repair	17723
@VP	labeling the major forelimb and hind-limb nerves , the median and sciatic nerves	17847
@VP	labeling central axons and terminals	18086
@VP	corresponding to the median and sciatic nerves , respectively	18290
@VP	were present at 2	18540
@VP	not shown	18559
@VP	approached but did not enter the lesion site -LRB- Figs. 4F and 4G -RRB-	18902
@VP	approached	18902
@VP	did not enter the lesion site -LRB- Figs. 4F and 4G -RRB-	18917
@VP	enter the lesion site -LRB- Figs. 4F and 4G -RRB-	18925
@VP	ascending sensory projections into the spinal cord lesion site	19040
@VP	is normally highly refractive to axonal growth	19160
@VP	compare Figs. 4D and 4F	19208
@VP	facilitate sparing of these axons at the lesion level and /	19248
@VP	prevent neuronal death	19310
@VP	did not observe CTB labeled axons progress beyond the lesion	19337
@VP	observe CTB labeled axons progress beyond the lesion	19345
@VP	labeled axons progress beyond the lesion	19357
@VP	progress beyond the lesion	19371
@VP	was	19867
@VP	observed in the CST at the lumbar level -LRB- Fig. 5H -RRB-	19896
@VP	reflecting the complete ablation of the dorsal column tracts	20049
@VP	To assess the repair of the CST	20111
@VP	assess the repair of the CST	20114
@VP	injected biotinylated dextran amine -LRB- BDA -RRB- into the motor cortex	20147
@VP	biotinylated dextran amine -LRB- BDA -RRB- into the motor cortex	20156
@VP	had retracted from the lesion	20439
@VP	retracted from the lesion	20443
@VP	were seen to progress beyond the lesion	20483
@VP	seen to progress beyond the lesion	20488
@VP	to progress beyond the lesion	20493
@VP	progress beyond the lesion	20496
@VP	-LSB- 35 -RSB- and references therein ; see below and Fig. 5	20524
@VP	-LSB- 35 -RSB- and references therein	20524
@VP	see below and Fig. 5	20553
@VP	see below	20553
@VP	Fig. 5	20567
@VP	sacrificed 2 and 4 weeks postinjury / transplantation	20587
@VP	not shown	20742
@VP	sacrificed 10 weeks after injury/transplant the CST	20772
@VP	injury/transplant the CST	20798
@VP	was labeled with higher molecular weight BDA -LRB- 10 kDa -RRB-	20824
@VP	labeled with higher molecular weight BDA -LRB- 10 kDa -RRB-	20828
@VP	was sprouting within this tract	20885
@VP	sprouting within this tract	20889
@VP	navigating into the lesion site between TEG3 cells	21138
@VP	saw sprouting -LRB- Figs. 5A and 5B -RRB-	21198
@VP	sprouting -LRB- Figs. 5A and 5B -RRB-	21202
@VP	could be detected at this level -LRB- Figs. 5A and 5C -RRB-	21386
@VP	be detected at this level -LRB- Figs. 5A and 5C -RRB-	21392
@VP	detected at this level -LRB- Figs. 5A and 5C -RRB-	21395
@VP	could be seen rostral to the lesion site -LRB- 21 ± 3.6 ; Figs. 5D and 5E -RRB-	21490
@VP	be seen rostral to the lesion site -LRB- 21 ± 3.6 ; Figs. 5D and 5E -RRB-	21496
@VP	seen rostral to the lesion site -LRB- 21 ± 3.6 ; Figs. 5D and 5E -RRB-	21499
@VP	found terminals at the level of the lesion site	21583
@VP	labeled fibers , if any , in the lesion site itself	21650
@VP	extending from the lesioned region	21703
@VP	indicate that TEG3 can mediate repair of the main descending motor	21979
@VP	can mediate repair of the main descending motor	21998
@VP	mediate repair of the main descending motor	22002
@VP	induced by TEG3	22189
@VP	-LSB- 35 -RSB- and references therein	22617
@VP	see Materials and Methods	22686
@VP	placed adhesive tape on the forepaw	22717
@VP	taken to sense -LRB- sensory ability -RRB-	22776
@VP	remove -LRB- motor ability -RRB- the tape	22813
@VP	had increased from 3 ± 2 to 43 ± 6 s and from 11.5	23103
@VP	increased from 3 ± 2 to 43 ± 6 s and from 11.5	23107
@VP	were 25.6 ± 8 and 24.7 ± 8 s for TEG3-transplanted animals -LRB- Fig. 6 -RRB-	23691
@VP	see supplementary video data	23935
@VP	made	24003
@VP	slips	24017
@VP	slips had increased from 0.8 ± 0.3 to 28 ± 4 , compared to unlesioned controls	24204
@VP	had increased from 0.8 ± 0.3 to 28 ± 4 , compared to unlesioned controls	24210
@VP	increased from 0.8 ± 0.3 to 28 ± 4 , compared to unlesioned controls	24214
@VP	produced a marked recovery of function from the first week onward	24313
@VP	lesion/transplant the number of foot	24548
@VP	slips	24585
@VP	was 2.8 ± 1 in the TEG3-transplanted group	24591
@VP	implanting TEG3 cells	24671
@VP	examined in this type of motor task	24744
@VP	demonstrated to be a valid strategy to recover spinal cord function after injury	24825
@VP	to be a valid strategy to recover spinal cord function after injury	24838
@VP	be a valid strategy to recover spinal cord function after injury	24841
@VP	to recover spinal cord function after injury	24861
@VP	recover spinal cord function after injury	24864
@VP	Immortalized	24907
@VP	constitute a feasible alternative to primary OEG	24930
@VP	have been established and characterized -LSB- 26 -- 30,36 -RSB-	24999
@VP	been established and characterized -LSB- 26 -- 30,36 -RSB-	25004
@VP	established and characterized -LSB- 26 -- 30,36 -RSB-	25009
@VP	derived from a single cell	25130
@VP	exhibits morphological plasticity both in culture and in vivo	25158
@VP	forming tumors	25297
@VP	needing any other accompanying cell	25398
@VP	is not an exception	25440
@VP	promoting axonal regeneration of mature neurons in culture -LSB- 29,30 -RSB-	25539
@VP	promoting CNS repair -LSB- 5,20 -RSB-	25733
@VP	is desirable for their characterization	25802
@VP	isolated	26375
@VP	characterized to express stably the nuclear TSV40 in culture -LSB- 29,30 -RSB-	26388
@VP	to express stably the nuclear TSV40 in culture -LSB- 29,30 -RSB-	26402
@VP	express stably the nuclear TSV40 in culture -LSB- 29,30 -RSB-	26405
@VP	be detected 4 weeks after transplant of TEG3 cells into the injured spinal cord	26517
@VP	detected 4 weeks after transplant of TEG3 cells into the injured spinal cord	26520
@VP	marking the TEG3 cells with BrdU	26601
@VP	transplanted into the injured spinal cord -LSB- 26,37 -RSB-	26799
@VP	indicating a general transgene shutoff mechanism in vivo	27033
@VP	did not decrease cell viability	27110
@VP	decrease cell viability	27118
@VP	to detect TEG3 cells after as much as 10 weeks after transplantation	27177
@VP	detect TEG3 cells after as much as 10 weeks after transplantation	27180
@VP	derived from transgenic mice for up to 28 days	27363
@VP	may depend on the original gene transfer method used -LSB- 39 -- 41 -RSB-	27681
@VP	depend on the original gene transfer method used -LSB- 39 -- 41 -RSB-	27685
@VP	used -LSB- 39 -- 41 -RSB-	27729
@VP	integrated into the spinal cord	27759
@VP	observed in culture	27853
@VP	may in part be responsible for their capacity to promote repair -LSB- 42 -RSB-	27941
@VP	be responsible for their capacity to promote repair -LSB- 42 -RSB-	27953
@VP	to promote repair -LSB- 42 -RSB-	27987
@VP	promote repair -LSB- 42 -RSB-	27990
@VP	did not observe extensive migration of TEG3 out of the lesion site	28014
@VP	observe extensive migration of TEG3 out of the lesion site	28022
@VP	did not generate tumors	28087
@VP	generate tumors	28095
@VP	did not observe mitotic figures in vivo	28118
@VP	observe mitotic figures in vivo	28126
@VP	described for other cells -LSB- 38 -RSB-	28302
@VP	has been observed with other cells -LSB- 38 -RSB-	28434
@VP	been observed with other cells -LSB- 38 -RSB-	28438
@VP	observed with other cells -LSB- 38 -RSB-	28443
@VP	mediate axonal repair in the spinal cord	28505
@VP	provoke recovery of sensory and motor function	28550
@VP	go through and beyond the lesion site in TEG3 - transplanted animals	28638
@VP	was regrowth of sensory projections into the lesion site	28726
@VP	navigating between the transplanted cells	28816
@VP	leaving the lesion site pass through regions free of TEG3	28945
@VP	pass through regions free of TEG3	28969
@VP	seem to be independent of their direct contact with the axons	29032
@VP	to be independent of their direct contact with the axons	29037
@VP	be independent of their direct contact with the axons	29040
@VP	act as a bridging/supporting substrate	29124
@VP	counteract the inhibitory influences of the glial scar	29166
@VP	was observed in the animals transplanted with TEG3	29285
@VP	observed in the animals transplanted with TEG3	29289
@VP	transplanted with TEG3	29313
@VP	were moderate in the tape removal test but quite marked in the beam walking test	29356
@VP	reached	29577
@VP	protect from the initial devastating effects of the injury	29659
@VP	later mediate functional recovery	29722
@VP	exiting the lesion territory	30133
@VP	be sufficient to reestablish the normal circuitry along the whole spinal cord	30200
@VP	to reestablish the normal circuitry along the whole spinal cord	30214
@VP	reestablish the normal circuitry along the whole spinal cord	30217
@VP	promoted by OEG	30319
@VP	published to date	30484
@VP	have demonstrated growth of regenerating axons through the lesion site	30502
@VP	demonstrated growth of regenerating axons through the lesion site	30507
@VP	regenerating axons through the lesion site	30530
@VP	see as examples -LSB- 16 -- 18,35,41,47 -RSB-	30703
@VP	resulting in spontaneous functional recovery in adult rats -LSB- 48 -RSB-	31081
@VP	implicated in the recovery of motor functions in the TEG3-transplanted animals	31286
@VP	of rubrospinal projections	31504
@VP	maintain neuroregenerative properties	31575
@VP	to play in the development of therapies to repair CNS lesions	31760
@VP	play in the development of therapies to repair CNS lesions	31763
@VP	to repair CNS lesions	31800
@VP	repair CNS lesions	31803
@VP	prepared from adult rat	32021
@VP	-LSB- 29,30 -RSB-	32061
@VP	supplemented with 10 % FCS	32110
@VP	supplemented with 10 % FCS , 20 µg/ml pituitary extract , and 2 µM forskolin	32153
@VP	follows the European Council Directive 86/609/EEC -LRB- 1986 -RRB-	32541
@VP	approved by national and institutional bioethics	32603
@VP	to promote neuronal repair	32685
@VP	promote neuronal repair	32688
@VP	were control unoperated animals	32812
@VP	underwent sham operations under anesthesia	32847
@VP	using watchmaker 's forceps -LSB- 35 -RSB-	33003
@VP	were transplanted with the TEG3 clonal line	33064
@VP	transplanted with the TEG3 clonal line	33069
@VP	received the cell suspension vehicle only -LRB- DMEM -RRB-	33142
@VP	To transplant TEG3 cells	33192
@VP	transplant TEG3 cells	33195
@VP	were injected with a Hamilton syringe coupled to a glass micropipette	33264
@VP	injected with a Hamilton syringe coupled to a glass micropipette	33269
@VP	at the lesion site and 1 mm caudal to	33418
@VP	rostral to the lesion -LRB- 1 µl/min/site ; a total of 3 Al -RRB-	33460
@VP	was sacrificed	33648
@VP	sacrificed	33652
@VP	ascending sensory projections and descending CST	33833
@VP	ascending sensory projections	33833
@VP	descending CST	33867
@VP	was induced -LRB- see Behavioral Assessment below -RRB-	34190
@VP	induced -LRB- see Behavioral Assessment below -RRB-	34194
@VP	see Behavioral Assessment below	34203
@VP	analyzed in behavioral tests 8 weeks after injury	34247
@VP	traced as described below	34298
@VP	described below	34308
@VP	sacrificed	34329
@VP	was fixed by transcardial perfusion 10 weeks after injury	34358
@VP	fixed by transcardial perfusion 10 weeks after injury	34362
@VP	comprising C1 -- C7 , approximately	34563
@VP	were collected from each animal	34621
@VP	collected from each animal	34626
@VP	were prepared	34780
@VP	prepared	34785
@VP	ascending and descending tracts of the dorsal columns	34839
@VP	was correlated with the functional recovery in sensory and motor performance	34893
@VP	correlated with the functional recovery in sensory and motor performance	34897
@VP	labeled	34971
@VP	described below	35116
@VP	diluted 1:500	35375
@VP	diluted 1:1000	35449
@VP	were visualized by immunofluorescence	35672
@VP	visualized by immunofluorescence	35677
@VP	were washed	35734
@VP	washed	35739
@VP	conjugated to FITC	35809
@VP	were washed and mounted with Fluoromount -LRB- Southern Biotechnologies -RRB-	35949
@VP	washed and mounted with Fluoromount -LRB- Southern Biotechnologies -RRB-	35954
@VP	were visualized in sagittal spinal cord sections with ExtrAvidin	36037
@VP	visualized in sagittal spinal cord sections with ExtrAvidin	36042
@VP	to	36816
@VP	corresponding to the center of the lesion	37060
@VP	represents 500 µm , the point 0 being the center of the lesion site	37195
@VP	being the center of the lesion site	37226
@VP	correspond to the areas rostral and caudal to the lesion site , respectively	37313
@VP	was performed using ANOVA	37412
@VP	performed using ANOVA	37416
@VP	using ANOVA	37426
@VP	was found to be significant	37453
@VP	found to be significant	37457
@VP	to be significant	37463
@VP	be significant	37466
@VP	are shown as they coincide with Bonferroni results	37588
@VP	shown as they coincide with Bonferroni results	37592
@VP	coincide with Bonferroni results	37606
@VP	-LSB- 35 -RSB- and references therein	37795
@VP	pretrained in both tasks on a daily basis 1 week before the injury/transplant	37851
@VP	was established	37969
@VP	established	37973
@VP	was immediately followed by transplantation of TEG3 -LRB- n = 6 -RRB-	38114
@VP	followed by transplantation of TEG3 -LRB- n = 6 -RRB-	38130
@VP	injury/transplant the animals	38361
@VP	was adapted from -LSB- 35 -RSB-	38519
@VP	adapted from -LSB- 35 -RSB-	38523
@VP	was placed on the left forepaw	38571
@VP	placed on the left forepaw	38575
@VP	taken to sense the presence of the tape -LRB- indicated by paw shake -RRB-	38615
@VP	to sense the presence of the tape -LRB- indicated by paw shake -RRB-	38621
@VP	sense the presence of the tape -LRB- indicated by paw shake -RRB-	38624
@VP	indicated by paw shake	38656
@VP	was determined	38680
@VP	determined	38684
@VP	sensed the tape	38713
@VP	was also scored	38747
@VP	also scored	38751
@VP	requiring sensorimotor integration	38804
@VP	was adapted from -LSB- 35	38840
@VP	adapted from -LSB- 35	38844
@VP	-RSB-	38860
@VP	were trained to cross a narrow metal beam -LRB- 3 x 90 cm -RRB-	38868
@VP	trained to cross a narrow metal beam -LRB- 3 x 90 cm -RRB-	38873
@VP	to cross a narrow metal beam -LRB- 3 x 90 cm -RRB-	38881
@VP	cross a narrow metal beam -LRB- 3 x 90 cm -RRB-	38884
@VP	see supplementary data video for examples	38980
@VP	slips was recorded -LRB- determined by the paw slipping off the beam -RRB-	39064
@VP	was recorded -LRB- determined by the paw slipping off the beam -RRB-	39070
@VP	recorded -LRB- determined by the paw slipping off the beam -RRB-	39074
@VP	determined by the paw slipping off the beam	39084
@VP	slipping off the beam	39106
